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Critical Review of the Literature Abstract 
With an increasing recognition of non-fear based emotions in the development and 
maintenance of Post-Traumatic Stress Disorder (PTSD), attention has been drawn to the 
proposed central role of guilt and shame. Cognitive models of guilt-based and shame-
based PTSD (Lee, Scragg & Turner, 2001) place emphasis on their role as mediating 
factors in the activation and development of guilt-based or shame-based schemas. Both 
guilt and shame have been suggested to be particularly pertinent emotions in perpetration-
induced trauma; that is, the development of PTSD in response one’s own actions. Whilst 
evidence supports the prevalence of perpetration-induced PTSD amongst offenders and in 
the military, amongst other professions; conclusions surrounding the proposed mediating 
role of guilt and shame in the relationship between perpetration trauma and the 
development of PTSD are yet to be drawn. This critical review consequently aims to 
investigate the proposed mediating role of guilt and shame in the development and 
maintenance of perpetration-induced PTSD. Results are discussed within the framework of 
Lee et al’s cognitive model of guilt-based and shame-based PTSD, with early evidence 
suggestive of a role of guilt and shame in cognitive processes. Whilst evidence remains 
scarce, avenues for further research are discussed. 
 
Keywords: Posttraumatic stress disorder; PTSD; perpetration-induced stress; shame; 

















Service Improvement Project Abstract 
Background. Lung transplantation is an established treatment option for many Cystic 
Fibrosis (CF) patients with advanced disease. Deciding whether to undergo transplantation 
is complex and services need to know how best to support patients and families. This 
study explores whether a Patient Decision Aid Tool (PtDA) could improve service 
provision in a UK NHS-based CF service.  
Method. A focus group was conducted with 10 clinicians from an adult CF service. Three 
interviews were conducted, one with an individual patient and two with patient and family 
pairs. An Australian PtDA provided an example. 
Results. The focus group and interviews were analysed separately utilising thematic 
analysis and then combined. Themes included meeting patient needs, accessibility, choice, 
communication, feeling prepared and developing the tool.  
Conclusions. A PtDA for lung transplantation was suggested to be beneficial. In spite of 
some challenges, it was felt to offer a number of improvements to service provision in an 
NHS CF service.  
 
Keywords: Cystic fibrosis; CF; lung transplant; patient decision aid tool; PtDA 
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Main Research Project Abstract 
Objectives. Mild cognitive impairment (MCI) is a common yet controversial diagnosis 
with marked heterogeneity in its’ diagnostic criteria and clinical outcomes. This 
heterogeneity brings with it uncertainty and ambiguity for both the clinicians working in 
memory services as well as the individuals who receive this label. This study aims to 
investigate the extent and role of health anxiety in individuals’ experiences of MCI, 
evaluating the impact of health anxiety (HA) on quality of life (QoL), perceived ability 
and health beliefs. 
Methods. Forty-five individuals with MCI completed questionnaires assessing HA, QoL, 
mood, functional ability and health beliefs. They also completed two cognitive tasks 
followed by self-ratings of perceived performance and attribution of their performance to 
MCI. Groups were compared based on their level of HA (low vs. high) and to a sample of 
non-impaired controls (n = 17). 
Results. The high HA group reported significantly reduced QoL as compared to the low 
HA group and healthy controls. No significant effect of HA was found on perceived 
performance or attribution of performance to MCI. Further exploratory analyses found 
significant mediational effects of depression and level of objective impairment on QoL, 
level of objective impairment on perceived performance, and generalised anxiety on health 
beliefs. 
Conclusions. In addition to a significant relationship between health anxiety and QoL in 
individuals with MCI, there is an important role for depression and level of objective 
impairment. 
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Guilt, Shame and Posttraumatic Stress Disorder (PTSD) 
Unlike other anxiety disorders, posttraumatic stress disorder (PTSD) is unique in 
its aetiology in the specification of the presence of an associated ‘event’ (i.e. a trauma) in 
its diagnostic criterion. Earlier conceptualisations of PTSD placed emphasis on the role of 
fear-based emotion in response to the traumatic event. However, recent revisions to 
diagnostic criteria have recognised the increasingly documented role of non-fear emotions 
in the development and maintenance of PTSD, including shame, guilt, anger and disgust 
(Lee, Scragg, & Turner, 2001). 
 
Consequently, the most recent edition of the Diagnostic and Statistical Manual of 
Mental Disorders, DSM V, (APA, 2013) removed the diagnostic specification of the 
peritraumatic response in PTSD as being characterised by “intense fear, helplessness or 
horror”. Given evidence of a broader spectrum of emotional complexity in PTSD, 
defining the emotional response was deemed inappropriate (APA, 2013).  However, this is 
not wholly supported with suggestions that it inappropriately broadens what can be 
deemed ‘traumatic’, serving only to further a conceptual ‘bracket creep’ (Spitzer, First, & 
Wakefield, 2007). 
 
Although once used interchangeably, guilt and shame are now recognised as 
distinct emotional states (Tangney, Miller, Flicker, & Barlow, 1996). Guilt is commonly 
defined as negative feelings towards a past action or behaviour with a focus on remorse 
and reparative action; whilst shame is suggested to be characterised by a more global 
negative evaluation of the self often associated with concealment and escape (Tangney & 
Dearing, 2002; Tangney, 1996).  
 
Guilt and shame have been proposed to be important emotional states in PTSD 
(McLean & Foa, 2016), and found to influence severity (Leskela, Dieperink, & Thuras, 
2002; Owens, Steger, Whitesell, & Herrera, 2009; Street & Arias, 2001) and treatment 
response (Kubany et al., 1995; Owens, Chard, & Ann Cox, 2008). Guilt in PTSD has been 
linked to the need for and possibility of restorative action. Kubany (1998) suggests that 
greater emotional distress can arise when the person’s need to repair is blocked,  driving a 
number of avoidance behaviours (e.g. alcohol, isolation) as a means of escape. Kubany 
and Manke (1995) also highlight a cognitive role of guilt centred around appraisals of 
responsibility, lack of justification and perceived violation of moral standards. 
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Further distinctions have been made between the experiences of shame in PTSD as 
internal versus external (Gilbert, 1998); internal shame being defined as the person’s view 
about themselves whilst external shame refers to the belief that other people perceive you 
as being inferior or damaged (akin to social anxiety (Clark & Wells, 1995). Both have 
been argued to occur either separately or co-morbidly, in the individuals’ appraisal of the 
traumatic event (Lee et al., 2001). In addition, shame has also been suggested to occur as 
both a primary (i.e. peritraumatic; Nathanson, 1994) and secondary (i.e. post-trauma 
appraisals; Ehlers & Steil, 1995) emotion in PTSD. 
 
With evidence supporting the relationship between PTSD and both shame 
(Andrews, Brewin, Rose, & Kirk, 2000; Leskela et al., 2002) and guilt (Joseph, 
Hodgkinson, Yule, & Williams, 1993; Kubany et al., 1996), Lee et al (2001) proposed a 
bi-directional cognitive model of guilt-based and shame-based PTSD (Figures 1.1 & 1.2). 
Akin to Ehlers and Clark’s (2000) well established cognitive model of PTSD, Lee et al 
(2001) emphasise the role of trauma appraisals in the development and maintenance of 
shame-based and guilt-based PTSD. Specifically, at the centre of Lee et al’s (2001) model 
is the congruence or incongruence of the person’s trauma appraisals with their pre-existing 
schemas. They propose the same mechanism for both emotions, with the difference in 
emotional response lying in the evaluation of meaning (i.e. whether appraisals are guilt-
based or shame-based). Specifically, shame and/or guilt are proposed to occur when the 
evaluated meaning of the trauma event is either congruent with pre-existing, latent shame 
or guilt-based schemas which are activated by the trauma appraisals, or incongruent with a 
pre-existing positive self-schema. When congruence occurs, the trauma appraisals serve to 
confirm a pre-existing negative schema attributed to the self. When incongruence occurs, 
the result is the formation of new shame or guilt-based beliefs. 
 19 
 




Figure 1.2: Cognitive Model of Guilt-based PTSD (Lee et al, 2001) 
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Clinically, it has been suggested that without addressing shame and guilt when 
they are present, the efficacy of PTSD interventions is impeded (Pitman et al., 1991; 
Resick & Schnicke, 1992; Riggs, Dancu, Gershuny, Greenberg, & Foa, 1992). 
Contrastingly, direct targeting of guilt and shame in therapy has been suggested to 
improve risk assessment and effectiveness of PTSD interventions (Bryan, Morrow, 
Etienne, & Ray‐Sannerud, 2013).  
 
PTSD and the perpetration of harm 
The concept of the ‘self-traumatised perpetrator’ (Young, 2002) arose from 
relatively early experimental research on PTSD in the military in the 1970s. Lifton (1973) 
spoke of a number of Vietnam veterans experiencing severe PTSD as a consequence of 
atrocities they committed against non-combatants, highlighting the potential for one’s own 
actions to act as a trauma. However, in spite of this early recognition, focus has largely 
remained on victims in PTSD. 
 
It is broadly accepted that the action of killing or harming another could act as a 
traumatic stressor for the person committing the act. What is at issue, however, is that the 
very nature of PTSD in identifying a ‘victim’ and a ‘perpetrator’ makes blame inherent, 
thus involving political and moral value judgement processes (McNally, 2010). For 
example, in response to the recognition that killing in war resulted in PTSD in those 
ordered to commit such acts, the presented ‘solution’ was to shift blame to the 
government, thus allowing individuals to once again be perceived as the victims of a 
bigger enemy (Fassin & Rechtman, 2009). Consequently, the scarcity of research in this 
area has been argued to be a matter of inattention rather than one of dispute (MacNair, 
2015). 
 
In broadening the diagnostic criterion surrounding what constitutes a ‘traumatic 
event’, the DSM-5 (APA, 2013) allows for perpetration to be classified as a trauma 
through the specified experience of “direct exposure” to death or harm. Although not 
named explicitly, in the accompanying discussion reference is also made to the act of 
“killing the enemy” as a potential source of trauma in the military. However, more explicit 
recognition is argued as warranted given a growing body of evidence of ‘perpetration-





PTSD and moral injury in the military 
The role of non-fear emotions in PTSD has been emphasised in the military as a 
consequence of the nature of combat-related trauma. Specifically, this type of trauma is 
often associated with ethical and moral transgressions, including perceived acts of betrayal 
(e.g. being unable to save a comrade; leadership failure), ‘survivor guilt’, and the 
perpetration of violence or killing when following orders (Drescher et al., 2011). Such 
moral transgressions have been found to be equally likely to elicit guilt and shame 
(Tangney et al., 1996). 
 
Combat-related harm, particularly killing, has been recognised as a significant risk 
factor for PTSD in serving personnel (Stern, 2014). Veterans who have actively killed 
experience higher rates and severity of PTSD in comparison with those who have 
witnessed death (MacNair, 2002) and are at a higher risk of dissociation, functional 
impairment, aggression, violence, relationship problems and alcohol abuse (Maguen et al., 
2010; Maguen et al., 2009). The risk of PTSD increases further in cases where a non-
combatant is killed, especially if female, a child or elderly (Maguen et al., 2013; Maguen 
et al., 2009). Within a context of the evolving nature of war, which is now frequently 
characterised by an unmarked enemy and civilian threats, the risk and prevalence of 
perpetration-induced PTSD in service personnel is likely to only continue to grow. 
 
The concept of ‘moral injury’ has arisen in the military literature; originally coined 
by Litz et al (2009) and defined as “the enduring consequences of perpetrating, failing to 
prevent, bearing witness to, or learning about acts that transgress deeply held moral 
beliefs and expectations” (Nash & Litz, 2013), p.368). Associated thoughts and feelings of 
shame, guilt and self-loathing have all been suggested to be characteristic (Drescher et al., 
2011) with Litz et al (2009) placing shame and guilt as central emotions in their social-
cognitive model. In line with Lee et al’s (2001) cognitive model of shame-based and guilt-
based PTSD, Litz et al (2009) place emphasis on the relationship between pre-existing 
beliefs about the self and trauma appraisals. In addition, they too highlight the relationship 
between these cognitive processes, feelings of guilt and/or shame and symptoms of PTSD, 
including intrusions, numbing, avoidance and withdrawal. 
 
Perpetration-induced PTSD in offenders 
MacNair’s (2002) concept of ‘perpetration-induced’ PTSD has also been extended 
into the field of offence-related trauma in forensic populations. It has been argued that 
crimes such as homicide and interpersonal violence can lead to PTSD (Lawrence & Taft, 
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2013; Papanastassiou, Waldron, Boyle, & Chesterman, 2004) and high rates of 
perpetration-induced trauma have been identified in both prisons and secure mental health 
units (Friel, White, & Hull, 2008). Estimated prevalence rates have varied, with reported 
rates falling between 15 – 58% (Papanastassiou et al., 2004; Payne, Watt, Rogers, & 
McMurran, 2008; Pollock, 1999; Spitzer et al., 2001). Spitzer et al (2001) found that in a 
population of 53 mentally ill offenders, the perpetrated offence was the second most 
common trauma causing PTSD after childhood sexual abuse.  
 
More recently, the role of perpetration-induced PTSD has also been suggested as 
applicable to gang membership (Kerig, Chaplo, Bennett, & Modrowski, 2016), due to acts 
of violence often being committed either as rites of passage, turf wars or as part of 
ongoing gang-related activity (Alleyne & Wood, 2012; Klein & Maxson, 2010; Taylor, 
Peterson, Esbensen, & Freng, 2007). Following the identified relationship between child 
soldiering and perpetration-induced PTSD (Betancourt, Newnham, McBain, & Brennan, 
2013; Klasen, Reissmann, Voss, & Okello, 2015), Kerig et al (2016) investigated this 
relationship in adolescent gang members and found that perpetration-induced violence 
predicted the variance in posttraumatic symptoms above and beyond trauma exposure 
among other factors.  
 
Aims of the review 
This review aims to explore the proposed relationship between PTSD, 
‘perpetration’ as trauma, and feelings of guilt and/or shame. In reviewing the relevant 
literature, the proposed mechanism of guilt and shame as mediating factors will be 
explored. Any additional factors explored in the relevant studies that may mediate this 
relationship will also be discussed. Based upon a model of mediation which proposes that 
the independent variable influences a mediating factor, which in turn mediates the 
dependent variable, mediation is determined via the degree to which the direct relationship 
between the independent variable and dependent variable is reduced by the inclusion of 
the mediating factor (Baron & Kenny, 1986). 
 
The results will then be considered within the context of the afore mentioned 
theoretical model of shame-based and guilt-based PTSD (Lee et al., 2001). Whilst the term 
‘perpetration’ may often be associated more with offenders, it is defined as a person who 
commits an illegal, harmful or immoral act; as such, the term is used more broadly 





Given that research in this area remains relatively scarce, there are insufficient 
high-quality research studies for a systematic review or meta-analysis to be completed. In 
addition, studies are collated across differing population groups and utilise an assortment 
of measures to explore the mechanisms central to this review, making direct comparability 
of measures across studies unfeasible. As such, this review conducts a systematic within a 
narrative synthesis of the literature. 
 
This critical review of the literature aims to answer the following question: 
 Is there a mediating role of guilt and shame in the development and maintenance of 
perpetration-induced PTSD? 
 Is there any evidenced association with the cognitive variables (i.e. schema 
congruence/incongruence, cognitive appraisals of trauma, evaluation of meaning) 
central to Lee et al’s model of shame-based and guilt-based PTSD? 
 
Inclusion/Exclusion criteria 
The following inclusion criteria was applied to the literature search: 
1. Publications must be written in English due to a lack of translation options. 
2. The population must all have perpetrated acts of harm, be classified into separate 
groups according to their trauma type (one of which must be perpetration relevant) 
or a measure of the degree of involvement in perpetrated acts must be utilised. 
3. Measures of PTSD and of guilt and/or shame must be included. 
4. The relationship between guilt and/or shame, perpetration and PTSD must be the 
focus of the study. 
5. The study must explore the mediating role of guilt/shame within the relationship of 
perpetration & PTSD. 
6. Participants must be adults (18 years). 
 
Search Method 
Potential studies to be included were identified via a search of five electronic 
academic literature databases: PsycInfo, Pubmed, Embase, Cochrane and Google Scholar. 
The following terms were included in the search strategy: 
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"PTSD" OR "posttraumatic stress*" OR "post traumatic stress*" OR "post traumatic 
stress disorder" OR "posttraumatic stress disorder" OR "traumatic stress" OR 
"perpetration-induced traumatic stress" AND "shame" OR "guilt" AND "combat" OR 
"perpetrat*" OR "violence" OR "kill*" OR "profess*" OR "offend*" OR "offence" 
 
A total of 642 articles were returned and were exported to covidence.org which 
was utilised as an online reviewing tool. After removal of duplicates (n = 15) and those 
screened out by title or abstract (n = 526), 103 articles were reviewed at the level of full 
text screening. A further 92 studies were removed at this stage (see Figure 1.3 for details), 
leaving 11 articles to be included in the review. Reference lists were also checked and did 





















Figure 1.3: Flowchart of literature review search strategy 
 
Data Extraction 
The following data was abstracted from each study; sample size and population, 
including the defined perpetration-based trauma; measures of PTSD, shame/guilt plus any 
Studies identified through 
database searching (n = 642) 
Removal of duplicates (n = 15) 
Studies screened by 
abstract (n = 627) 
Articles removed (n = 526) 
Articles removed & reasons:  
No measure of 
PTSD/shame/guilt (n = 33) 
Non-perpetrators (n = 11) 
Age < 18 (n=2) 
Wrong sample (n = 10) 
Trauma type undefined (n = 7) 
Grey literature (n = 7) 
No English translation (n = 1) 
Wrong study focus (n = 21) 
Full text assessed for 
eligibility (n = 103) 
Studies included in 
critical review (n = 11) 
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additional variables; type of analysis used; results detailing the relationship between 
PTSD, perpetration and guilt/shame including any mediating relationship; and results 
detailing any relationship with the cognitive variables outlined in Lee et al’s (2001) model. 
See Table 1.1 for a summary. 
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Table 1.1: Summary of Studies included in the Review 
 




PTSD measure Guilt/Shame 
Measure 




Stein et al (2012) 122 active duty 
service members 
diagnosed with PTSD 
(US military).  
 
Heterogenous trauma 
types across sample; 
focus on those 
traumas classified by 
authors as ‘Moral 
Injury by Self’ (MIS) 
(i.e. having killed or 
harmed another) 




Version (PSS-I) (Foa, 






































(PTCI) (Foa, Ehlers, 












MIS and posttrauma 
reactions: Humiliated 
(r = 0.21), Sad (r = 
0.26), Numb (r = 








= 0.39, p = 0.003); 
TRGI Wrongdoing 
( = 0.26, p = 0.043); 
PSS-I re-
experiencing 
subscale ( = 0.28, p 
= 0.015); PTCI 
negative cognitions 
about the self, 
marginal result ( = 











Jones & Sheu 
(2014) 
Data from 1,203 









via measure of 
involvement in 
abusive violence rated 
on 6-point Likert scale 
(range from 0 = not at 
all to 6 = I was 
responsible) 
Predicted probability 
index of PTSD; 
Diagnostic Interview 
Schedule (DIS) 
symptom count & 
Mississippi Combat 
Scale (MCS; Keane, 
Caddell & Taylor, 
1988) 
Guilt 
3-item forced choice 
(‘yes’ or ‘no’) measure 
of guilt. 
Drug Use 
2-item forced choice 
(‘yes’ or ‘no) measure 
with diagnostic 




2-item forced choice 
(‘yes’ or ‘no) measure 
with diagnostic 




2-item forced choice 
(‘yes’ or ‘no) measure 
with diagnostic 








direct effect on 
PTSD ( = 0.15, p < 
0.001) & guilt ( = 
0.19, p < 0.01) as 
mediating factor. 
Direct effect on 
PTSD and guilt as 
co-mediating factors 
( = 0.44, p < 0.001).  
 
Model provided good 
fit to the data 2(151) 
= 196.79, p = 0.007. 
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Shea, Presseau, 
Finley, Reddy & 
Spofford (2016) 
206 National Guard 
and Reserve Unit 
Veterans who had 






type in sample; for 
purpose of this review 
focus on those 
classified as ‘having 
killed’ (n = 26); 
divided into ‘killed 
the enemy’ (n = 23) & 
‘killed a non-





IV; Blake et al, 
1995). 
Guilt 
Sum of two CAPS-IV 















having killed and 




having killed and 
severity of PTSD 




& Kirby (1998) 
151 help-seeking 
Vietnam veterans in 
an outpatient PTSD 
clinic (US military). 
 
Perpetration classified 
through a six-item 
subscale from the 
Vietnam Era Stress 
Inventory (Wilson & 




Mississippi Scale for 
Combat-related 
PTSD (MSC; Keane 





Blake et al, 1995); 
Davidson Trauma 
Scale (DTS; 





Kubany et al, 1996) 
Degree of combat 
exposure 
Combat Exposure 
Scale (CES; Keane, 
Caddell, & Taylor, 
1988) 
 
Index of interpersonal 
violence 
Overall Violence 
Index (OVI), a 
subscale of Conflict-























to TRGI Global (r = 
0.34), TRGI Distress 
(r = 0.24), TRGI 
cognitions (r = 0.23), 
TRGI hindsight 
bias/responsibility (r 
= 0.2) & TRGI 
wrongdoing (r = 
0.33); all ps < 0.05). 
 
Atrocities exposure 
not related to TRGI 
lack of justification 




to overall PTSD 
severity ( = 0.54 – 
0.82); symptoms of 
avoidance & 
emotional numbing 
( = 0.34); TRGI 
overall guilt ( = 
0.04); TRGI guilt 




= 0.03); and TRGI 
wrongdoing ( = 
0.01), all ps < 0.05.   
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Hendin & Pollinger 
Haas (1991) 
100 Vietnam veterans 
(US military). 
 
Type of perpetration 




hoc analyses to 
determine if nature of 
trauma differentiated 
the two groups. 
Revised Combat 
Scale (Egendorf et al, 
1981), a checklist of 
PTSD symptoms 
based on the DSM-III 
diagnostic criteria & 
clinical interviews. 
Guilt 
Coded data from 
clinical interviews: 
split into ‘guilt about 
combat actions’ and 
‘survivor guilt’. 
Measures of suicide 
attempts & suicidal 
ideation 






Coded data from 
clinical interviews. 
Chi-square tests with 




























Guilt about combat 
actions significant in 
veterans who 
committed suicide 
attempts (2 = 14.24, 
df = 1, p < 0.001) but 
not in nonsuicidal 
veterans.  
 
Guilt about combat 
actions significant in 
veterans with 
suicidal ideation (2 







feelings of “out of 
control” in suicide 
attempters with 
greater involvement 
in atrocities (2 = 




Guilt about combat 
actions (=9.16) and 
depression (=1.95) 
as two significant 
predictors in suicide 




Guilt about combat 
actions ( = 1.45) s 
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significant predictor 
in suicidal ideation 
model. 






classified through a 
six-item subscale 
from the Vietnam Era 
Stress Inventory 
(Wilson & Krauss, 














(Beck, Steer & 
Brown, 1996) – single 
item as a measure of 
suicidal ideation & 
remaining 20 items as 






Hostility Scale (Cook 





Violence subscale of 
the Conflicts Tactics 






Scale (CES; Keane, 













to test mediation of 
indirect effects. 
All measures of guilt 
on TRGI correlated 
significantly at p < 






Significant (p < 0.05) 
identified direct 
pathways: Atrocities 








Atrocities  Guilt 
 PTSD ( = 0.07);  
Atrocities  Guilt 
 PTSD  Hostility 
( = 0.2); Combat 
Exposure  
Atrocities  Guilt 
 PTSD  Hostility 













via measure of 
agency: Atrocities 
Exposure subscale of 
DRRI, expanded to 
include 16 additional 
items related to direct 
perpetration of 
atrocities. 
 PTSD Checklist 
(PCL; 
Weathers, Litz, 










Adapted version of 
Combat Experiences 
subscale (removal of 
agency questions) 
from the Deployment 
Risk and Resiliance 
Inventory (DRRI; 
King et al, 2003). 
 
Exposure to aftermath 





Exposure to atrocities 
Adapted Atrocities 
Exposure (removal of 
agency questions) 






































Guilt accounted for 
16% of variance over 
and above exposure 
(0.4%), perceived 
threat (0.3%) & 
agency (0.02%). Age 
( = 2.84) & guilt ( 
= 14.06) remained 
significant predictors 
of PTSD. Guilt 
shared variance with 




Guilt had a 
significant mediation 
effect between 
exposure & PTSD 
(indirect effect of 
1.34, 99% CI, p < 
0.001); between 
perceived threat & 
PTSD (indirect effect 
of 0.96, 99% CI, p < 
0.01); & between 
agency & PTSD 
(indirect effect of 




Bolton, Nash & Litz 
(2017) 
867 active duty 
Marines previously 





subscale of Moral 
Injury Event Scale 





Litz, Herman, Huska 
& Keane, 1993). 
Guilt and Shame 
Positive and Negative 
Affect Schedule 
(PANAS; Watson, 
Clark & Tellegan, 
1988) – adapted to 
measure emotions of 
‘Ashamed’ and 
‘Guilty’ through a 




Scale (CES) from the 
Deployment Risk and 
Resiliance Inventory 









































on guilt/shame ( = 
0.26, p < 0.05); 
guilt/shame on PTSD 






guilt/shame  PTSD 
( = 0.09, p = 0.08);  
 
Model provided good 
fit to the data 2(239, 
526) = 538.55, p < 
0.001 
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Marx et al (2010) 1,323 Vietnam 
veterans taking part in 




by War Stress 
Inventory (WSI; 
Rosenheck & 
Fontana, 1989)   
Structured Clinical 
Interview for DSM-
III-R (SCID; Spitzer, 










III-R (SCID; Spitzer, 






Scale (CES; Keane, 
















in abusive violence 
exerted an indirect 
effect on both PTSD 
(effect = 0.20, p < 
0.001) & MDD 
(effect = 0.12, p < 
0.001) via combat 
related guilt.  
 
Magnitude of 
indirect effect nearly 
2x greater for PTSD 
than MD; minimal 
overlap in 95% CI 
(.31 - .52 PTSD; .16 
- .32 MDD).  
 
Variance explained 
by model: 52% 
PTSD & 17% MDD.  
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from an inpatient 
secure unit (UK). 
 
Perpetration 
All participants had 
committed an offence 
of a violent or sexual 
nature and had 
admitted the offence. 
Independent ratings of 
severity made by 
researcher plus 2 
clinicians & mean of 
3 independent ratings 










Positive and Negative 
Affect 





























difference in guilt 
scores between 
known vs. unknown 
victims (t(41) = 2.03, 
p = 0.05). Greater 
guilt with unknown 
victims. 
 
Guilt (β = 0.34) 
significantly 
increased variance 
from 43% to 54% 
(F(1, 38) = 9.02, p = 
0.05) in predicting 
trauma 
symptomology. 
Negative affect (β = 
0.384) and offence 
severity (β = 0.271) 
were also significant 
in the model (p < 
0.05)  
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Sippel & Marshall 
(2011) 
47 individuals 
currently in a couple 
where interpersonal 
violence has been 





measured via the 
Revised Conflicts 













emotional Stroop task 
– supraliminal (word 
displayed until vocal 
response) & 
subliminal (word 
masked after set time 





encoding task – 
indicate whether 
shame words describe 
self by ‘yes’ or ‘no’ 
response 
None Mediation models – 







processing speed (β 
= -0.35, p < 0.05); 
subliminal shame 
processing speed on 
IPV perpetration 
frequency (β = -0.37, 
p < 0.05); PTSD on 
supraliminal shame 
processing (β = -




effect of subliminal 
shame processing 
speed in the effect of 
PTSD severity on 
IPV perpetration (M 
= 0.0058, SE = 
0.0054, 95% CI = 
0.0048 – 0.0165). 
Partial mediation 
effect of subliminal 
shame processing 
speed in the effect of 
PTSD severity on 
IPV perpetration (M 
= 0.0004, SE = 
0.0033, 95% CI = 




Overview of studies 
The selected studies explored the relationship between perpetration-induced PTSD 
and shame and/or guilt across two populations: military personnel/veterans and 
violent/sexual offenders. All studies were reviewed in terms of the mediating effect of 
feelings of guilt or shame in the relationship between perpetration as a trauma event and 
PTSD. Table 1.1 provides a summary of all the studies included and the key findings. 
 
Characteristics of the studies 
Military studies 
Nine of the reviewed papers focussed on the military.  All studies were conducted 
in the United States. Two of the papers explored actively serving soldiers whilst the 
remaining seven explored veterans. Five studies recruited veterans from the Vietnam war 
whilst three recruited veterans who had been deployed to Afghanistan or Iraq. All studies 
utilised a cross-sectional design. None included a control group. Sample sizes ranged from 
23 to 1,323. Samples were drawn from large research cohort studies of military personnel 
(Currier, Holland, Jones, & Sheu, 2014; Jordan, Eisen, Bolton, Nash, & Litz, 2017; Marx 
et al., 2010; Stein et al., 2012), post-deployment health assessments (Shea, Presseau, 
Finley, Reddy, & Spofford, 2016), outpatient PTSD clinics (Beckham, Feldman, & Kirby, 
1998; Dennis et al., 2017), military hospitals (Hendin & Haas, 1991), and online 
recruitment via veteran organisations and professionals working with veterans (Huang & 
Kashubeck‐West, 2015). Identified acts of perpetration covered combat-related actions 
such as killing or harming the enemy, as well as involvement in additional war-related 
“atrocities” such as killing or harming non-combatants, torturing prisoners or mutilating 
dead bodies. Eight of the nine identified studies focused on the role of guilt alone, whilst 
the remaining study utilised a combined measure of both guilt and shame. 
 
Offender populations 
Two of the reviewed papers focussed on offenders. Studies were conducted in the 
United States (n = 1) and the United Kingdom (n = 1).  One study included violent and 
sexual offenders (Crisford, Dare, & Evangeli, 2008) whilst the other utilised a community 
sample of couples with a history of interpersonal violence (Sippel & Marshall, 2011). 
Both utilised a cross-sectional design. Neither included a control group. Sample sizes 
ranged from 45 to 47. Samples were drawn from a secure unit (Crisford et al., 2008) and 
through a larger scale research trial (Sippel & Marshall, 2011). Identified acts of 
perpetration included violent and sexual offences (Crisford et al., 2008) and non-
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criminalised interpersonal violence (Sippel & Marshall, 2011). Crisford et al (2008) 




Measures of PTSD 
Eleven different measures were used as a means of quantifying the severity of 
PTSD. Two studies utilised multiple measures. Currier et al (2014) used two measures; the 
first was a predicted probability index of PTSD, derived by the researchers through 
logistic regression using a symptom count and adjustment measures from a Diagnostic 
Interview Schedule (DIS) alongside demographic variables & the Mississippi Combat 
Scale (MCS; Keane, Caddell, & Taylor, 1988). The probability index ranged from 0 to 1 
and was reported as a “strong estimate” of PTSD. In addition, 15 further items from the 
MCS were included as a measure of different clusters of symptomology; namely re-
experiencing (five items), avoidance (five items) and hyperarousal (five items). The MCS 
is s self-report measure with items rated on a 5-point scale.  
 
Beckham et al (1998) also used multiple measures, again utilising the MCS 
alongside the Clinician-administered PTSD Scale Diagnostic version (CAPS; Blake et al., 
1995) and the Davidson Trauma Scale (DTS; Davidson et al., 1997) The DTS is a self-
report scale measuring frequency and severity of PTSD as a total score as well as by 
symptom clusters (B, C and D scores). The CAPS is a structured interview also assessing 
PTSD frequency and severity and symptom clusters, including two guilt related items. 
The remaining seven studies used a single measure. Shea et al (2016) and Sippel and 
Marshall (2011) also opted for the CAPS, whilst Dennis et al (2017) also used the DTS. 
Stein et al (2012) utilised the PTSD Symptom Scale, Interview Version (PSS-I; Foa, 
Riggs, Dancu, & Rothbaum, 1993); a 17 item semi-structured interview which measures 
severity of PTSD relevant to a single trauma event.   
 
The remaining four measures were the Revised Combat Scale (RCS; Egendorf, 
1981), a checklist of PTSD symptoms based on the DSM-III diagnostic criteria & clinical 
interviews; the Structured Clinical Interview (SCID; Spitzer, Williams, Gibbon, & First, 
1992) for DSM-III-R, the Detailed Assessment of Posttraumatic Stress (DAPS; Briere, 




Measures of Guilt 
Two standardised measures of guilt were used; the Trauma Related Guilt Inventory 
(TRGI; Kubany et al., 1996) and the Laufer-Parson Guilt Inventory (LPGI; Laufer & Frey-
Wouters, 1988). The TRGI is a 32-item self-report scale assessing cognitive and emotional 
aspects of guilt on a 5-point Likert scale. It comprises of a global guilt scale, a distress 
scale and a guilt cognitions scale (with three subscales: Hindsight-Bias/Responsibility, 
Wrongdoing, and Lack of Justification) and was the most commonly used measure being 
utilised in four of the nine studies investigating the role of guilt (Beckham et al., 1998; 
Crisford et al., 2008; Dennis et al., 2017; Stein et al., 2012). The LPGI was employed by 
two of the remaining five studies (Huang & Kashubeck‐West, 2015; Marx et al., 2010); a 
33 item self-report scale designed to measure combat-related guilt on a 5-point Likert 
scale.  
 
In the remaining three studies measuring guilt, Currier et al (2014) used three ‘yes’ 
or ‘no’ questions as a means of measuring combat-related guilt; Shea et al (2016) utilised 
the two guilt-based questions of the CAPS; and Hendin and Haas (1991) used data coded 
from clinical interviews as representing feelings of guilt. 
 
Jordan et al (2017) used a combined measure of guilt and shame by combining the 
scores for emotions identified as ‘Ashamed’ and ‘Guilty’ on the Positive and Negative 
Affect Schedule (PANAS; Watson, Clark, & Tellegen, 1988). The PANAS is a self-report 
measure traditionally used to measure positive and negative emotions on a 5-point scale, 
covering 20 different emotions when used in its original form. 
 
Measures of Shame 
Only one study measured shame as an independent variable. Sippel and Marshall 
(2011) developed an emotional stroop task which assessed participants processing speed to 
shame-based and neutral words. Words were presented electronically on a black 
background and participants were asked to name the colour of the word. Two forms of this 
task were developed; a supraliminal version where the word remained on the screen until a 
vocal response was given, and a subliminal version where the word was replaced by a 
mask of the same colour after a set time which then remained until a vocal response was 
given. In addition, participants also completed a self-referential encoding task whereby 
participants indicated whether shame-relevant words reflected their beliefs about 




The Relationship between Guilt, Perpetration and PTSD 
Eight of the nine studies investigating the association between guilt, degree of 




Five studies (Beckham et al., 1998; Dennis et al., 2017; Huang & Kashubeck‐
West, 2015; Jordan et al., 2017; Marx et al., 2010) described a significant role for guilt in 
the relationship between involvement in acts of perpetration and PTSD severity. Of these 
five studies, four of them utilised means of measuring mediation through the use of 
Bootstrapping (Dennis et al., 2017; Huang & Kashuback-West, 2015), path analysis (Marx 
et al., 2010) and Structural Equation Modelling (SEM) (Jordan et al. 2017), providing 
analytical evidence of guilt as a mediating factor.  Beckham et al (1998) did not provide a 
measure of mediation. Two studies (Currier et al., 2014; Stein et al., 2012) reported an 
inverse relationship between PTSD severity in the relationship between perpetration and 
guilt. Stein et al (2012) did not include a measure of mediation to demonstrate this 
suggestion, whilst Currier et al (2014) measured mediation utilising SEM. See appendices 
A – C for models of these relationships (plus any identified co-variates) presented by the 
authors in three of the nine studies (Currier et al., 2014; Dennis et al., 2017; Marx et al., 
2010). Huang & Kashubeck-West (2015) found the mediation effect of guilt predicted 
variance above and beyond combat exposure and perceived threat. 
 
Exploration of the symptoms of PTSD found significant effects of perpetration on 
symptoms of avoidance and numbing (Beckham et al., 1998) as well as re-experiencing 
(Stein et al., 2012) within models of guilt, perpetration and PTSD. 
 
Marx et al (2010) found that guilt not only mediated the relationship between 
perpetration and PTSD, but had a significant indirect effect on MDD also; although, the 
magnitude of the variance was 2x that of MDD in PTSD. Dennis et al (2017) also found 
significant mediating effects of guilt on depression, hostility and aggression alongside 
within models of severity of PTSD and involvement in perpetration. 
 
Shea et al (2016) did not replicate other studies, evidencing no significant 
relationships between any of the three key identified variables (PTSD, guilt and 
perpetration) for those classified in their sample as ’having killed’ (enemy or non-
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combatants, n = 26) in combat. One possible reason for their contrasting non-significant 
result may be the use of actively serving soldiers as opposed to veterans. Active service 
members were also used in Stein et al’s (2012) study which found a significant result in 
line with other studies included in this review. 
 
However, whilst Stein et al (2012) shared a host of similarities with Shea et al 
(2016), including classifying their sample similarly according to trauma type and 
comparable sample sizes and populations, one noted difference in the samples is whether 
service personnel had been formally diagnosed with PTSD. In Shea et al’s (2016) study, 
severity of PTSD symptoms was investigated in the absence of a formal diagnosis whilst 
participants in Stein et al (2012) were diagnosed with PTSD prior to participating in the 
study. It is possible that the differing level of PTSD severity may have accounted for the 
contrasting results. Another possible explanation for Shea et al’s (2016) non-significance 
could also lie in their measure of guilt; they utilised two CAPS items from the PTSD scale 
as a measure of guilt as opposed to a standardised instrument. 
 
 Offender Studies 
Crisford et al (2008) also evidenced a significant mediating role of guilt in 
predicting the relationship between degree of perpetration on PTSD severity alongside 
negative affect and offence severity. Mediation was reported via an increase in variance 
accounted for by the addition of guilt, which significantly increased the variance from 
43% to 54%. A significant difference in guilt was also found between those offenders 
whose victims were known vs. unknown, with greater guilt in those who did not know 
their victim. 
 
The Relationship between Shame, Perpetration and PTSD  
Only two studies focused on the relationship between shame in perpetration-
induced trauma and PTSD severity. In addition, only one of these two studies focused on 
shame as an independent variable (Sippel & Marshall, 2011), whilst the other (Jordan et 
al., 2017) discussed a combined variable of both guilt and shame. 
 
Military studies 
The military study compared the combined factor of guilt and shame (Jordan et al., 
2017). It found marginally significant indirect effects of guilt and shame on PTSD in 
perpetration of harm. This was in contrast to similar relationships between anger as a 
mediator of acts of betrayal and dissociation as a mediator of danger-based combat 
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exposure. This distinction was suggested to evidence a particular role of guilt and shame 
in perpetration-based traumas as compared with other trauma types. See Appendix D for 
the reported model. Mediation was analysed via SEM. 
 
 Offender studies 
Sippel and Marhsall (2011) reported a significant mediating effect of subliminal 
shame processing speed on an emotional stroop task in the relationship between IPV 
perpetration and PTSD severity. Bootstrapping techniques were used to analyse mediation. 
 
The Role of Cognitive Variables in the Relationship between Guilt/Shame and 
Perpetration-induced PTSD 
 
 Military Studies 
Exploration of different dimensions of guilt identified significant effects of 
perpetration on the role of hindsight/responsibility and a sense of wrongdoing but not lack 
of justification (as measured by the TRGI) on PTSD in military personnel (Beckham et al., 
1998; Stein et al., 2012). Additionally, Beckham et al (1998) also found the same 
relationship with guilt cognitions on the TRGI; a similar finding to Stein et al (2012) who 
found an effect of perpetration on negative cognitions about the self in PTSD within a 
model of perpetration, guilt and PTSD. 
 
Consideration of other co-variates also highlighted a significant difference across 
group comparisons in the degree of guilt felt about perpetrated actions in suicidal veterans 
with PTSD (both attempts and ideation groups) as compared to nonsuicidal veterans 
(Hendin & Haas, 1991) alongside a significant association between perpetration and 
peritraumatic feelings of being “out of control” in suicide attempters. 
 
 Offender Studies 
Sippel and Marshall (2011) also found significant correlations between number of 
selected shame self-descriptive words and both PTSD severity, degree of perpetration of 
IPV and shame processing speed on the stroop tasks. They concluded that their results 
supported the role of a shame processing bias in the development of perpetration-induced 






This review has found some evidence to support the mediating role of guilt in the 
relationship between involvement in perpetration as a trauma and the severity of PTSD 
within the context of varying means of mediation analyses. Evidence from those studies 
which utilised statistical analyses of mediation such as Bootstrapping and SEM, all 
reported significant effects with all ps < 0.05. A similar relationship has also been 
demonstrated for shame; however, given that only one included study focused directly on 
shame, conclusions are unable to be drawn and further research on the mediating effect on 
shame are warranted.  
 
Evidence for the mediating role of guilt in the relationship between perpetration 
and PTSD supports its role as a central mechanism in the development and/or maintenance 
of PTSD in those who experience the effects of a self-perpetrated trauma. This is 
supportive of Lee et al’s (2001) model of guilt-based PTSD. The centrality of shame in 
Lee et al’s shame-based model of PTSD was also supported; but significantly limited by 
the scarcity of evidence.  
 
In considering the mechanisms involved in the relationship between guilt/shame 
and PTSD, Lee et al (2001) proposed a central role of cognitive appraisals and self-
focused schema in the development of PTSD symptomology. Investigation of differing 
dimensions of guilt as measured by the TRGI identified a significant mediating role for a 
sense of responsibility and wrongdoing on PTSD severity (Beckham et al., 1998; Stein et 
al., 2012). This sense of disparity with an individual’s personal (i.e. responsibility) sense 
of what they believe to be right and wrong (i.e. wrongdoing) is akin to Lee et al’s (2001) 
identified incongruence between pre-existing schemas of the self and trauma appraisals. In 
addition, this relationship was found to exist in the absence of a lack of justification (as 
measured by the TRGI), emphasising the importance of the individual’s meaning 
attributed to their actions (i.e. their cognitive appraisals of the perpetration trauma), 
regardless of how it is more widely viewed or justified by others. This finding is 
particularly pertinent in consideration of the role of perpetration-induced PTSD within the 
military and other occupations, whereby justification of actions by employers and 
occupation-related training should not be assumed to be protective of guilt-based or 
shame-based PTSD.  
 
Cognitive appraisals were also supported as a mechanism in this review through 
the evidenced role of guilt cognitions (Beckham et al., 1998), negative thoughts about the 
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self (Stein et al., 2012) and shame schemas (Sippel & Marshall, 2011). Once again, this 
can be argued to be supportive of the central role of pre-existing schemas as well as the 
development of new negative beliefs in Lee et al’s (2001) model. In addition, the finding 
is also supportive of the central role of cognitive factors in the NICE recommended 
cognitive behavioural therapy (CBT) treatment for PTSD (NICE, 2005). However, in light 
of some evidence noted during the full text screening for this review which suggested that 
some components of traditional PTSD interventions may cause more harm than benefit in 
shame-based PTSD (Maguen & Burkman, 2013). As such further research on the 
treatment of shame-based and guilt-based PTSD is warranted. 
 
The role of both re-experiencing (Stein et al., 2012) and avoidance (Beckham et 
al., 1998) symptomology in guilt-based PTSD are also supported by the studies included 
in the review; both of these symptoms being highlighted in the models of shame-based and 
guilt-based PTSD (Lee et al., 2001) as well as the traditional cognitive model of PTSD 
(Ehlers & Clark, 2000). 
 
It is noteworthy that significantly more studies focused on the role of guilt as 
compared to shame, perhaps due to a higher prevalence of guilt in PTSD as compared to 
shame, or alternatively presenting a bias in the literature. Comparative research on the 
differing prevalence rates of guilt and shame in PTSD could prove to be of interest in this 
regard, including figures on their co-occurrence. Furthermore, a distinction in this review 
also exists such that all military studies included in the review measured guilt, with the 
exception of one which reported a combined guilt and shame measure. Contrastingly, 
shame was only measured independently in the offender studies. This distinction in 
emotion focus is interesting, particularly given that both emotions have been evidenced to 
be predictors of PTSD (McLean & Foa, 2016) and related to moral transgressions 
(Tangney, 1996), and carry equal weight in relevant theoretical models (Lee et al., 2001).  
 
Considering the definitions of guilt and shame within the context of the different 
acts of perpetration and the associated social and cultural perceptions, it seems fitting that 
lawfully sanctioned perpetrators (consciously or unconsciously) bring with them a focus 
on guilt (“I did a bad thing”) whilst a focus on shame is present in perpetrators of criminal 
acts (“I am a bad person”). Future research would benefit from diversifying this focus such 
that the role of both emotions across both populations are investigated. This would also 
allow for a comparative exploration of the significance of each emotion in the two 
populations. One example would be to explore whether the non-significant result found in 
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the ‘Lack of Justification’ subscale in the TRGI (as opposed to other subscales) in military 
personnel would be a valid distinction in the offender population also given the unlawful 
nature of their act as compared to the sanctioned actions of a serving soldier. 
 
In addition to providing early support for the mechanisms of the development and 
maintenance of PTSD highlighted by current theoretical models, the review also 
highlighted a number of additional areas for exploration in understanding further possible 
mediating factors in guilt-based and shame-based PTSD. For example, the role of hostility 
and aggression (Dennis et al., 2017) and a possible associated peri-traumatic feeling of 
being “out of control” (Hendin & Haas, 1991).  
 
Finally, possible associated consequences of guilt in perpetration-induced PTSD 
were highlighted in military studies; namely, suicidality (Hendin & Haas, 1991); post-
trauma emotions of ‘sad’ as well as depression and MDD (Dennis et al., 2017; Marx et al., 
2010; Stein et al., 2012); and aggression and hostility (Dennis et al., 2017). Within the 
context of perpetration of harm being a hazard of their occupation, the importance of fully 
understanding the impact of this aspect of their role on mental health is key; particularly 
given recent figures from the US Department of Veteran Affairs estimating that in the 
USA (where all military studies in this review were conducted) one veteran dies by suicide 
every 80 minutes (Harrell & Berglass, 2011). Exploration of whether the mechanisms of 
such effects by guilt are specific to perpetration or whether this is part of a broader 
relationship between guilt, PTSD and these dependent variables would also be warranted. 
Furthermore, understanding these relationships in the context of offender populations 
would also be justified. 
 
Limitations 
The findings of the review need to be considered in the context of the 
methodological limitations of those studies included in the review. All studies included are 
cross-sectional in their design meaning that conclusions surrounding the role of causality 
and directionality in the relationship between variables cannot be drawn. This is particular 
pertinent when considering the results within the context of Lee et al’s (2001) model 
which offers a longitudinal perspective in suggesting a theoretical direction of this 
relationship (i.e. that shame or guilt schemas are either pre-existing and become activated 
by post-trauma appraisals, or subsequently develop as a result of peritraumatic appraisals 
of guilt or shame). Whilst this longitudinal element is difficult to investigate, consideration 
could be given to the development of experimental methodologies to explore the 
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possibility of a causal relationship between guilt and shame trauma appraisals and schema 
activation or development; for example, utilising guilt or shame based vignettes as a 
parallel. 
 
In addition, sample sizes varied significantly across studies and those with smaller 
sample sizes may be underpowered meaning that whilst valuable contributions, the 
generalisability of their results are likely limited. Furthermore, three of the larger studies 
were based upon retrospective secondary data analysis; a method which has been criticised 
relevant to the validity of such studies (McNally, 2003). 
 
None of the studies included a control group, meaning that comparison of the 
mechanisms in victims vs. perpetrators was not feasible. Inclusion of a comparative group 
would allow for firmer conclusions to be drawn surrounding the specificity of the 
mechanisms as linked to acts of perpetration as a trauma. 
 
All military studies were conducted within the USA and given differing natures of 
armed forces across countries, the applicability of the results to the UK armed forces is 
limited. Other demographics of note was that the majority of participants in the studies 
were male. Given suggestions that a gender difference exists between the severity of 
PTSD, coping and trauma-related guilt in the armed forces (Hensley, unpublished), the 
generalisability of these findings is limited and additional research warranted in 
understanding any gender differences in the context of perpetration-induced PTSD. 
 
Although some studies did use well validated instruments like the SCID or CAPS 
for PTSD, and the TRGI and LPGI for guilt, the reliability and validity of tools varied 
significantly across studies with some studies using a limited number of researcher-
selected forced choice ‘yes’ or ‘no’ questions or interview data coded by the researchers; 
both of which are subject to experimenter bias. This limits the comparability of the results 
across studies and warrants further high-quality research utilising standardised measures 
with good levels of reliability and validity.  
 
It is important to consider possible confounding variables. Whilst some studies 
explored the possible confounding role of degree of combat related exposure in the 
military studies, specific consideration of possible co-founding sources of trauma based 
upon a non-perpetration trauma was not considered. This is also important in the offending 
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populations, where it is known that offenders may likely also have a history of traumatic 
experiences as a ‘victim’ of trauma prior to the offence. 
 
In addition to the methodological limitations of the studies included in this review, 
it is also important to consider the limitations of the literature review itself. Use of Google 
Scholar as part of the search procedure has its’ limitations. These include the absence of 
controlled vocabulary and a whole text search strategy which can result in the retrieval of 
a number of inaccurate citations. However, on the contrary, Google Scholar’s less precise 
search strategy has a broader reach, including covering multiple disciplines and multiple 
document types including gray literature (although excluded from this review due to 
accessibility constraints). Consideration of these advantages and disadvantages in relation 
to literature reviews has suggested that use of Google Scholar should be accompanied by 
other academic databases in order to ensure the best possible coverage of the literature 
using this search engine (Shultz, 2007). Furthermore, within the context of a systematic 
review, it is also worthy to note that the algorithm of Google Scholar is changed regularly 
which impacts significantly on the ability to replicate the search accurately.  
 
Furthermore, whilst the methodological quality of the studies included in the 
review is critically discussed throughout, inclusion of a quality assessment tool would 
have provided an objective measure of the quality of the studies included. This would 




Clinical implications of this review include the importance of therapists’ 
consideration of the potential role of guilt and/or shame in the development of PTSD. This 
is particularly significant given evidence indicative of a lack of effectiveness of traditional 
interventions for PTSD such as CBT (Steenkamp, Nash, Lebowitz, & Litz, 2013) with 
suggestions that the exposure components of such treatments may in fact exacerbate 
shame-based reactions to transgressive events (Maguen & Burkman, 2013). As such, 
evaluation of the current NICE recommended means of treating PTSD as well as 
consideration of alternative interventions would be warranted in further research in this 
field. For example, one study considered at the full text level of this review highlighted the 
importance of addressing compassion for the traumatised self when working with shame-
based PTSD in military personnel (Alliger-Horn, Zimmermann, & Schmucker, 2016). 
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Consideration of therapist views may also be warranted given the controversial nature of 
working with a traumatised perpetrator.  
 
In addition, throughout the screening process of this review, what became apparent 
is the increasing recognition of the role of perpetration-induced PTSD beyond the military 
into other occupations including slaughterhouse workers, veterinarians, medical 
professionals (including ‘medical error’ in the case of surgeons, medical consultants, 
paramedics and midwives) and police (Dillard, 2008; Komarovskaya et al., 2011; R. 
MacNair, 2002; Victor & Barnard, 2016; Wahlberg et al., 2016; Whiting & Marion, 2011). 
In comparison to the military population, research into the role of PTSD in other 
professions remains minimal. This may be reflective of a much-reduced prevalence rate in 
these populations as compared with the military. Nevertheless, killing or seriously injuring 
another in a professional role remains a significant predictor of PTSD for other 
populations also (for example, police officers; Komarovskaya et al., 2011). This highlights 
the importance of further research considering the wider reach of perpetration-related 
PTSD in the context of one’s occupation. With the literature surrounding the relationship 
between these professions and PTSD being scarce, exploration of the mechanisms of this 
relationship is absent meaning that no additional professions were included in this review. 
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Lung transplantation in Cystic Fibrosis 
There are currently over 10,000 people living with Cystic Fibrosis (CF) in the UK 
(Cystic Fibrosis Trust, 2015). CF is a hereditary disease which causes excessive mucus 
secretions, primarily affecting the pancreas and lungs and causing significant pulmonary 
damage. As medical knowledge and treatment develops, survival rates have improved 
significantly with the recent predicted age of survival being greater than 50 years (Dodge, 
Lewis, Stanton, & Wilsher, 2007). Consequently, CF is no longer considered a childhood 
disease and focus on long-term management has increased (Goldbeck, Fidika, Herle, & 
Quittner, 2014). 
 
Lung transplantation has become an established treatment option for many patients 
with advanced disease (Mall, 2014) and the Cystic Fibrosis Trust has consequently called 
for improved access to transplantation (Cystic Fibrosis Trust, 2014). Nevertheless, it does 
not come without difficulties and significant complications post-transplant are common 
(Cystic Fibrosis Trust, 2013). Current figures suggest that in the UK, NHS transplants see 
an average survival rate of approximately 8.1 years, although this figure varies 
significantly (Cystic Fibrosis Trust, 2015). Unsurprisingly, the decision to go ahead with 
lung transplantation is complex and difficult. 
 
Patient Decision Aid Tools 
One suggestion of how services can better support patients and their families with 
complex decision-making is through the use of patient decision aid tools (PtDAs) 
(O'Connor et al., 2009). Coulter (2013) outlined the overarching goals of PtDAs as 
addressing inadequate knowledge and unrealistic expectations, reducing unwanted 
pressure and improving support. Use of these tools has also been suggested to support 
shared decision making; a concept at the centre of many UK healthcare policies (Lansley, 
2010).  
 
Over 80 RCTs support the efficacy of PtDAs in supporting complex decision 
making in chronic physical health problems (O'Connor et al., 2009), including one 
utilising a PtDA in lung transplantation in CF (Vandemheen et al., 2009). Vandemheen et 
al (2009) demonstrated the PtDA to be a beneficial adjunct to care as usual in reducing 
decisional conflict, increasing patient knowledge and understanding of the procedure, 
process and associated risks, facilitating more realistic expectations and improving patient 
satisfaction with the decision-making process.  
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However, despite substantial support from RCTs, implementing PtDAs in routine 
practice is not without challenges. Elwyn et al (2013) outlined the need for services to 
understand how to best use such tools. In line with this, O’Connor (1998) highlights the 
importance of considering clinical characteristics such as patient and provider perceptions 
of decisional support at the earliest stage of PtDA development. Current research 
surrounding the utilisation of a PtDA for lung transplantation in CF exists within the 
Australian and Canadian healthcare systems only. It has not yet been replicated within a 
UK NHS-based service. Without sufficient consideration of the service context, services 
are suggested to be at risk of causing harm as opposed to improving care (Coulter et al., 
2013). 
 
The Service: Bristol Adult Cystic Fibrosis Centre 
Bristol Adult Cystic Fibrosis Centre is a specialist centre providing 
multidisciplinary care to adults with CF across the South West. The team comprises two 
consultant physicians, 5 CF nurses, 4 physiotherapists, 2 dieticians, 2 clinical 
psychologists, 2 pharmacists and a social worker. The service is directly attached to the 
Bristol Paediatric CF service, although also accepts referrals from other paediatric 
services. 
 
Aims of the Study 
The purpose of this study was to explore whether introducing a PtDA into a UK 
NHS-based service could improve patient care for adults with CF considering lung 
transplantation.  At this early stage of development, the clinical needs of the service, 
patients and carers were evaluated. A qualitative approach was taken to reflect the 
exploratory nature of the research. A full evaluation of clinician, patient and carer views 
about current levels of support within the CF service was completed alongside exploring 
whether a PtDA for lung transplantation could improve care provision. Vandemheen’s et 
al (2009) PtDA was offered as an example to support consideration of how such a tool 




Following consultation with the Clinical Lead and Clinical Psychologist, research 




1. Is current service provision for lung transplantation meeting patients’ needs? 
2. Would the introduction of a PtDA improve service provision? 
3. What would the potential benefits of introducing a PtDA be? 
4. What would the challenges of introducing a PtDA be?  
5. What adjustments would need to be made to ensure the PtDA was meaningful to 
    the service? 
6.  If a PtDA was introduced, how should it be delivered? 
 
These questions formed the basis of the focus group and interviews and were asked 
after provision of a brief outline of the aims of a PtDA and research to date (via 
PowerPoint presentation to clinicians (Appendix G) and verbally to patients and family).   
All participants were provided with a copy of the PtDA (Vandenheem et al., 2009) 
(Appendix H). Questions were delivered flexibly with prompts whilst remaining 
sufficiently open to allow important aspects to be identified by participants. 
 
Participants 
Data saturation (Glaser & Strauss, 2009) is the guiding principle by which sample 
size in qualitative research should be determined. When data saturation is achieved, 
content validity can be concluded (Francis et al., 2010). In the current study, recruitment 
of patients and family members was necessarily limited by the inclusion criteria set by the 
service; due to the sensitive nature of the topic, participants had to have undergone lung 
transplantation, be on the waiting list for one, or were a family member of a patient in 
either position. This limited pure data saturation but analysis demonstrated significant 
overlap in data coding and emerging themes, demonstrating adequate content validity. 
 
All clinicians currently working in the service were invited to take part with the 
aim of capturing a multidisciplinary perspective. Participants were 10 clinicians (C1 – 
C10); a Consultant Physician, Registrar, Dietician, Nurses, Clinical Psychologists and 
Physiotherapists. 3 patients (P1 – P3) and 2 family members (F1 – F2) took part in the 








Age Gender Patient/Significant Other Lung transplantation 
status 
P1 20s F Patient Awaiting lung 
transplantation 
F1 50s F Carer Parent of P1 
P2 20s F Patient Undergone lung 
transplantation 
F2 40s F Carer Parent of P2 
P3 50s F Patient Awaiting lung 
transplantation 
Table 2.1: Demographic information for patients and family members 
 
Procedure 
Invitations to attend the focus group were sent to clinicians via secure email. The 
focus group took place during time allocated for a team meeting at the Bristol Adult CF 
Centre. The focus group and interviews lasted between 45mins – 1hour, were audio-
recorded, transcribed verbatim and anonymised. 
 
Potential patients were approached by known clinicians from the service; six were 
identified, however three were not included as one had a significant health event, one died 
and the other declined inclusion. The remaining three were provided with an information 
sheet and contacted by the lead researcher within 7 days to arrange a convenient time to 
meet. The researcher then asked the patient if they could identify a family member who 
would be interested in participating also. Two patients invited a parent to attend and one 
patient declined. The interview with the individual patient also took place at the Bristol 
Adult CF Centre during a routine hospital admission. The two patient/family interviews 
took place in their place of residence.  
 
Analysis 
Analysis and transcription were conducted as parallel processes.  The lead 
researcher conducted the interviews, transcribed and analysed the data. Analysis followed 
the six-phase guide to thematic analysis outlined by Braun & Clark (2006) with initial 
coding completed inductively and the service’s research questions acting as a deductive 
framework for later stages of analysis. This is in line with the Thematic Framework 
Method (Gale, Heath, Cameron, Rashid, & Redwood, 2013; Ritchie, Lewis, Nicholls, & 
Ormston, 2013) 
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After transcription, the researcher read each transcript several times, to promote 
data familiarity, and search for patterns of meaning. Initial codes were noted onto the 
transcripts and linked to relevant extracts. Coding began using an inductive process, as this 
allowed for the richness of the original data to be captured. These initial codes were then 
grouped together using a deductive approach, guided by the research questions, and 
linking together codes that had shared similarities in meaning to generate meaningful and 
valid ‘themes’  
 
In an attempt to capture the full richness of a theme, conflicting codes were 
included together for consideration. Transcripts were re-read frequently throughout this 
process. Within each identified theme, codes were organised into subthemes to more 
closely capture the essence of the original transcripts. 
 
Once initial analysis was complete, a second rater analysed a sub-set of the data. 
The second rater, a Clinical Psychologist in training with experience of working within the 
Bristol adult CF service, offered an informed and alternative perspective on the data. The 
second rater first reviewed the coding of one theme in detail and then reviewed the 
remaining themes and subthemes based on a subset of codes within each. They were then 
consulted on the proposal to merge two themes that had initially been distinct. Their 
analysis fed into the final analysis and review of the themes. Examples included retaining 
the merged theme due to inter-rater agreement, merging subthemes due to identified 
overlap and assistance in defining subthemes which led to a high level of inter-rater 
agreement on the remaining themes when discussed. 
 
Statement of position 
 The researcher positioned themselves within a phenomenological framework as a 
means of attempting to capture the experiences of the participants taking part in the study. 
Within this framework, they considered themselves to be approaching the data from an 
experiential viewpoint, whilst also recognising a constructionist influence given the role of 
the service’s research questions as a deductive framework in analysis. The researcher is a 
Clinical Psychologist in training who does not have any experience of working with adults 
with Cystic Fibrosis. A deliberate decision was made to limit the researcher’s knowledge 
of the lung transplant process so as to not to create any biases on the participants’ views on 





The study was assessed and approved by The University of Bath Psychology 
Department Research Ethics Committee. Full NHS ethics was not required as the study 
met criteria for service evaluation. All participants were provided with information sheets 
and gave consent to participate in the knowledge that their data would be anonymised and 
that they could withdraw at any time. 
 
Results 
A significant overlap was found in themes arising from data provided by staff, 
patients and carers, so all themes are reported together. Six super-ordinate themes were 
extracted from the data: 1) ‘Meeting needs’; 2) ‘Accessibility’’; 3) ‘Choice’’; 4) 
‘Communication’; 5) ‘Being prepared’; 6) ‘Developing the tool’ (see Appendix I for 
thematic map). These super-ordinate themes and their sub-themes are outlined below, 
illustrated by specific quotations. 
 
1. Meeting patient needs 
Patients reported variability in how well the service met their needs when deciding 
whether to proceed with lung transplant. They suggested that the PtDA may have a role in 
enhancing support. 
 
1.1 The need for information 
Patients and their families suggested that informational support needs were 
scarcely met by current service provision. Specifically, knowledge of the transplant 
process, potential advantages and disadvantages, transplant aftercare and possible 
outcomes post-transplant: 
 
“…well we just didn’t have any information…we didn’t know how it worked or what it 
entailed… it would have been beneficial to know” (P1). 
 
One patient interpreted this lack of information as the service not having the 
knowledge to disseminate to patients: 
 
“…to be honest, they don’t know a great deal I don’t think. They just sort of say about it 
and then the rest is up to you to…find out really…I don’t think they want to give the 
information because they don’t know.” (P1).  
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This lack of knowledge led some patients to do their own (online) research, and the 
potential dangers of doing this were acknowledged by patients and staff. Clinicians 
suggested that addressing this gap through the PtDA would ensure that accurate 
information is received: 
 
“patients who are anxious are probably surfing the net anyway and at least we have got 
some control over what is in the content of this” (C4)  
 
Another patient spoke of the absence of information acting as a barrier to asking 
questions: 
 
“…it is also a question of me having the knowledge to ask them what might happen and I 
don’t think I have that knowledge…I don’t know what to ask...” (P3) 
 
Patients and family felt that the PtDA could address the identified gaps, and thus 
make decisions more informed: 
 
“…I think this would have definitely made the decision process…more 
knowledgeable…everything is there… how your life can be with the transplant but there is 
also without the transplant…you have everything you need before you to make that 
decision…I personally think it is brilliant and would’ve been really helpful to have.” (F2). 
 
1.2 Emotional support 
The need for emotional support was emphasised by patients and family, all 
describing positive experiences of emotional support by the team: 
 
“the team themselves are really supportive” (P1) 
“…the support I have received has been very good…” (P3) 
 
One patient identified difficulties forming new relationships and building trust 
after her transition from paediatric to adult services as a barrier to accessing emotional 




“…just a more friendly and understanding level rather than…being a bit more 
professional about it because that’s when I put my guard up because I just thought they 
were telling me things…” (P2) 
 
The PtDA was suggested as having an emotionally supportive role in addition to 
improving knowledge: 
 
“I think it is pretty much on point…feeling supported through it, to have this…” (F2). 
 
1.3 Supporting physical health 
One patient suggested that support focused too much on physical health 
preparations for transplant and that non-physical needs should be met too:   
 
“… it was more about the physical stuff and it was all about my weight…there was good 
communication for physical stuff too but the other support, it felt like it didn’t kick in soon 
enough...” (P2) 
 
1.4 Tool as an adjunct  
The role of the PtDA was regarded by both patients and staff as being best placed 
as an adjunct to the existing service: 
 
“…you’d have the information…but also if you’re giving it to them in clinic you can talk 
through the numbers at that point…It’s not something you just send off in the post and say 
see you later. You know it’s something that you would then have a discussion with 
them…” (C3) 
 
Risks of giving the PtDA-based information alone were suggested by both staff 
and family as having the potential to overwhelm some individuals due to the difficult 
emotions that can be involved in making the decision: 
 
“I think one of the things that slightly concerns me is whether people um kind of naively go 
and look at the decision aid and think they’ll be able to cope with it and then come 
overwrought.” (C4) 
 
One clinician thought the front-sheet of the PtDA should inform patients that they 
can discuss the information with their team: 
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“I mean that’s something that you could put on the front-sheet, couldn’t you? In terms of 
saying that it’s for you and then the other ways are to talk to your team, psychology 
support, and all that kind of thing…” (C2) 
 
In order to reflect the team approach, both staff and patients felt that the PtDA 
could be introduced and reviewed by any member of the multidisciplinary team: 
 




Equal access to the PtDA and the information it provides was suggested to be an 
important factor in considering its’ use within the service. 
 
2.1 Information being available 
Clinicians and patients felt that the PtDA should be widely accessible, at all time 
points along the care pathway and that patients should be able to choose when to access 
the PtDA: 
 
“if they wanted to know about it and felt ready for it then yeah I don’t see the problem” 
(P2) 
 
However, one patient spoke of the importance of not giving information at a time 
when it may be too anxiety-provoking, suggesting a need for the team to balance patient 
choice with clinical judgement when introducing the PtDA: 
 
“…if you’re not at that stage…it might worry them even more and they may not need to be 
thinking about it” (P2) 
 
All participant groups mentioned the benefits of widening access to include family 
members as well as patients. As lung transplantation decisions are not made alone, having 
informational support via the PtDA would benefit families too: 
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“oh yeah make it widely available to families so anybody can access that information. Yes, 
it is ultimately the patient goes through the process but we need to know that too, we need 
to know what they are going through” (F2). 
 
2.2 Information being understandable 
Accessibility of information in the PtDA requires clarity and comprehensibility as 
well as physical access. One parent praised the simplicity of the language used in aiding 
her ability to understand otherwise complex medical information: 
 
“…it is simple, it doesn’t use medical terms for anything that you don’t piggin’ 
understand, it’s just so simple…” (F2) 
 
Supporting the written information with pictures and graphs was also suggested to 
be helpful in ensuring that the message is clear: 
 
“I think that it’s really helpful having the pictoral form as well” (C5) 
 
3. Choice 
Promoting and respecting patient choice when introducing the PtDA was seen as 
crucial by both clinicians and patients, given the complexity of the decision-making 
process.  
 
3.1 Choosing how and when to use the tool 
In considering the ‘readiness’ of patients to receive and process the information 
presented by the PtDA, patients and family suggested the right time as being a choice they 
make: 
 
 “…I think I pigeonholed this, I’m not gonna worry about that now… I knew it was there 
but kind of I don’t need to deal with that at this moment thank you.” (F2) 
 
Clinicians suggested the PtDA could act as a means by which patients can make 
this choice: 
 
“they can read at a time when they’re not too stressed about it. I think that’s really 
important because it could be hard to process all that information at a time when you are 
trying to make that decision…” (C5)  
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Clinicians and patients thought that having a choice of modality of the PtDA 
(online or on paper) would help: 
 
 “(having paper and online copies) gives the patient choice so it feels much less 
paternalistic than what medicine could be like, it sort of gives the information when it is 
useful and needed” (C4). 
 
 “…because some people might…prefer it on email or online so they can get hold of it 
when they want to…whereas when it is on paper, it’s like it’s there…also online you have 
to be interested in looking for it and reading it whereas on paper it’s here all the time and 
you can put it to one side…” (P2). 
Clinicians also highlighted the relationship between choice, engagement, and 
having options:  
 
 “…you could make it (a quiz) an optional thing and say something like if you wanted to 
check that you have taken this in…but yeah I wouldn’t make it a sort of mandatory part of 
the decision aid” (C5) 
 
3.2 Choice to make and change the decision 
All patients discussed how their decision changed multiple times and highlighted 
the importance of feeling in control. Two patients said they had felt supported by the team 
to make their own choice: 
 
 “The support I’ve had has been very good and nobody had pushed me into making that 
decision, it has been entirely mine.” (P3) 
 
One patient and her mother spoke of a need to ensure clinical judgement doesn’t 
overshadow patient choice: 
 
 “...before I felt like people were saying I have to do it…and I sort of rebelled…” (P2) 
“...this is helping you make a decision from that very start, we didn’t have that decision, 
we were just referred.” (F2) 
 
Clinicians outlined the importance of supporting patients with changing decisions: 
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“…saying that you’ve got time to make that decision and you have the choice of changing 
that because I think a lot of people worry that once they’ve said one thing then you can’t 
go back and change it so I think that having that clear throughout...” (C6) 
 
Both clinicians and patients spoke of the neutrality of the PtDA as being in keeping 
with the promotion of patient choice: 
 
“…it’s quite benign, it’s not really edited, not really pushing one way or the other.” (C1) 
 
However, concerns were raised by groups about timing; highlighting the tensions 
between promoting patient choice within the context of a declining health condition: 
 
“…that decision can change but they have to be aware that actually it it’s left too late then 
you might not have a choice about it” (C3). 
 
4. Communication 
Another benefit of the PtDA was using it as a communication tool between staff, 
patients, family, and services.  
 
4.1 Communication across services 
Communication between services was an area that could be improved: 
 
“…there should be more communication…. I don’t actually know whether one team 
communicated with the other…” (F2) 
 
The potential of using the PtDA as a consistent tool that patients bring to 
appointments with services at transition points was highlighted, specifically from the CF 
team to the transplant centre and from paediatric to adult services. In addition, it was 
suggested to enhance direct communication between services about patient readiness for 
transplant. This was considered to be a way of reducing anxiety when speaking to other 
professionals: 
 
“…so if you’ve got something that is already familiar to you that makes them a bit more 




4.2 Starting conversations 
The PtDA was seen as a way of starting conversations with patients that the team 
may have not otherwise instigated, perhaps if their clinical judgement made them unsure 
about patient readiness. Consequently, the PtDA could help with reaching out to more 
patients and families: 
 
“I think for me where this feels like it’s helpful is for the people who we don’t even know 
are thinking about transplant” (C1) 
 
5. Feeling prepared 
All patients and family members described how the conversation about lung 
transplant came as a shock, for which they felt unprepared: 
 
“I had like never heard about it being done before in like CF, it’s sort of shocked me 
because I didn’t know that like that was an option” (P1) 
 
The PtDA could improve care by preparing patients for this discussion. 
 
5.1 Drip-feeding information 
One patient spoke of the benefits of having information about lung transplant in 
the PtDA early on in their care:  
 
“…drip feeding it slowly so it isn’t a shock” (P1) 
 
5.2 Seeing change over time 
Patients and staff suggested that routine use of the tool in clinic make all parties 
aware of health changes over time, potentially ameliorating the shock of being told they 
are unwell enough to have a lung transplant: 
 
“…maybe if you see it gradually coming like this in this sort of form you would gradually 
become aware or accepting of eventually these things are gonna happen and it won’t be, 
not such a shock but you’d perhaps be able to cope with it a bit better yeah” (F1) 
 
This use of the PtDA could give patients and families a more realistic picture of 
their health and treatment options:  
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 “…it was a shock in a way because I thought am I really ill enough for a lung transplant? 
This would of brought me back to reality…” (P3) 
 
The ‘tick boxes’ were suggested as particularly useful in tracking change over time: 
 
 “I think it might be beneficial to use the tick boxes like to go through it every so often” 
(P1) 
 
6. Developing the tool 
All participants spoke positively about the supportive nature of the example PtDA. 
Various developments and adaptations were suggested to improve the tool and ensure it 
could be used meaningfully within the service. 
 
6.1 Making service specific developments 
The need to adapt the Australian version of the PtDA to reflect the UK National 
Healthcare System and UK facts and figures for CF was highlighted. The content was seen 
to need amendments so that it fitted with the service and was more meaningful for 
patients: 
 
“…it’s something to develop so the tool is specific to us” (C3) 
 
One team member emphasised the need to evaluate the PtDA after any 
developments and subsequent introduction into the service: 
 
“if we developed it, how would we, would we try to evaluate? How would we plan to 
evaluate its use?” (C3). 
 
6.2 Future development  
The team described possibilities for further expansion of the PtDA to continue to 
improve their service. For example, by developing a child-friendly PtDA: 
 
“…in some ways it might be something that’s got potential, it would be nice to have like a 
younger version, a child-friendly version for parents to go through with their 
children…we’ve had requests already, you know, how do I explain this to my child?” (C4) 
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This would improve conversations between the team and the children of parents 
with CF. This linked to the theme of ‘Communication’ between paediatric and adult CF 
services, and improvements in the transition process.   
 
One patient and her mother also suggested including the patient voice in the tool, 
sharing valuable lived-experience of someone who had already undergone lung transplant: 
 
“…maybe giving a little bit of help from someone who has had a transplant who has been 
there trying to make the decision” (P2). 
 
Discussion 
Evaluation of current service provision suggested that although patients and their 
families feel supported in managing the emotional impact of the lung transplant decision-
making process, significant gaps exist in the availability of information. This suggests that 
the Bristol adult CF service could benefit from developing their informational support, 
with a particular emphasis on balancing the different types of support available to their 
service users.  
 
The PtDA was seen to offer multiple benefits for service provision. An important 
part of this was as a way of improving informational support, but other aspects were also 
important, including enhancement of emotional support and communication. The strongest 
themes to arise around the benefits of the PtDA focused on how it could: improve access 
to clear and accurate information for all patients and their families; provide a neutral 
means of weighing up a complex decision without influence; and encourage regular, 
routine conversations between clinicians and patients. These benefits are closely aligned to 
the overarching goals of PtDA’s (Coulter,  2013) of addressing inadequate knowledge and 
unrealistic expectations, reducing unwanted pressure and improving support. The data also 
support the role of a PtDA in improving shared decision making through the promotion of 
shared monitoring of health status and treatment options (Lansley, 2010). 
 
However, introducing a new tool is has challenges and potential concerns about 
developing a PtDA in the Bristol adult CF were highlighted. The team should be able to 
respond to these concerns so patients are not put at risk (Coulter et al., 2013). This requires 
the balancing of clinical responsibility and duty of care with patient choice and 
information provision in a way that is supportive and not overwhelming. One such tension 
that the team will need to consider carefully when developing the tool further, is ensuring 
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patients and families are fully aware of the limits of the decision (i.e. when other factors 
will deem them unable to have a transplant) without influencing their choice. 
 
The need to adapt and tailor an example PtDA to the specific service (and the UK 
healthcare system more generally) was seen as important, demonstrating how critical it is 
to  explore and use input from services, clinicians and patients at the early stage of PtDA 
development (Elwyn et al., 2013; O'connor et al., 1998). Similarly, it is not sufficient for 
benefits to be assumed, and any tool development must be properly evaluated to ensure it 
meets patient and service requirements.  
 
Overall, this study demonstrated staff, patients and families’ enthusiasm for the 
PtDA and its acceptability. To build on this further, research should now be conducted in 
the development, implementation and evaluation of a PtDA within the service. If such 
evaluation studies suggest it leads to measureable benefits, then a larger RCT could be 
explored (e.g. Vandemheen et al., 2009). It could also be of interest to explore the use of a 
PtDA within paediatric services too.  
 
Limitations 
This study aimed to explore the use of a PtDA in a single service for adults so data 
were gathered from a small sample. Consequently, conclusions regarding the acceptability 
of a PtDA in CF services in the UK more generally cannot be drawn. In addition, given the 
sensitive nature of this topic, patients included were either on the transplant list or had 
undergone transplant. Given suggestions that earlier introduction of information would be 
beneficial, consideration of the views of patients for whom lung transplant has not yet 
been discussed would be warranted.  
 
Recommendations for the service 
From the resulting themes, a number of recommendations for the Bristol adult CF 
service were made as outlined in Table 2.2. The lead researcher presented these 
recommendations at a subsequent team meeting and discussed ways in which the resulting 
recommendations could be implemented. The recommendations were also circulated to the 
team via secure email after the meeting. Given the beneficial role that the PtDA could 
have in improving service provision, the team are keen to begin to take steps to develop a 





PtDA content 1. Facts, figures and information included in the tool need 
to be adapted from the Australian example to accurately 
represent a UK context 
2. Important factors to be considered in developing the 
content include the accuracy of the information presented, 
including the source from which it is obtained, and the 
clarity with which it is presented 
3. Avoid medical language and ensure that the information 
is simple and factual in nature 
4. Clearly state on the front of the PtDA that the 
information contained within the PtDA can be discussed 
with their CF team  
5. Emphasise within the PtDA that the decision is theirs and 
that this can change 
6. Make clear the limits of the decision; for example, when 
that choice to have a transplant may no longer be viable 
 
PtDA formatting 1. Include pictures and graphs as a means of supporting the 
written information content 
2. Both a paper and online copy should be made available 
to allow patients a choice of how and when they access the 
information 
3. Quiz section of the PtDA should be made optional   
4. Include the tick box summary sheet as a snapshot of 
where the person’s health is currently in their consideration 
of whether this may be an option 
 
Introducing the PtDA 1. The PtDA should be an adjunct to usual clinical care 
from the team and as such its introduction may be best 
placed alongside discussion from a team member   
2. The PtDA can be introduced by any member of the team  
3. The introduction of the PtDA should be a routine part of 
care for all patients 
4. Patient choice in how and when they choose to access 
and engage with the Information should be respected. 
Related to this, all patients should be given both a paper 
copy as well as a link to the online version so they have 
choice in how they wish to access the tool 
5. Introduce the tool not only to patients themselves but 
also ensure significant others, including family, are aware 
of the PtDA and its use and are able to access it if they feel 
it would be helpful  
6. Introducing the tool earlier in the care pathway has been 
suggested as a means of increasing preparation for the 
decision-making process through gradual awareness and 
acceptance of the information presented. Gaining views of 
patients earlier on in the pathway would be beneficial in 
considering this further 
7. Whilst promoting patient choice is key to its 
implementation, a role for clinical judgement has also been 
suggested to be beneficial in ensuring that individuals do 
not become overwhelmed by the information without the 
necessary support in place 
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Ongoing use of the PtDA 
across the care pathway 
1.  Regularly use the PtDA at clinic appointments as a 
means of making the information a routine part of patient 
care 
2. Routinely complete the tick box summary sheet as a 
means of tracking change over time and enabling all parties 
to see when and why lung transplant should be considered 
as a viable treatment option if and when the time comes 
3. Explore the possibility of utilising this tool as a means of 
communicating with other services (e.g. transplant centres 
and paediatric services) to aid transitions for patients 
 
Ensuring it is meeting the 
outlined needs  
1. Once the tool has been developed, evaluation of its use in 
the service would be warranted 
 
Further developments 1. Consideration of developing a child-friendly version of 
the PtDA in the future should initial introduction be 
evaluated positively 
2. Consider developing the tool further to include 
descriptions of the experience of making the decision from 
the perspectives of patients and family members alongside 
the factual information provided. Given the praise 
surrounding the neutrality of the document, whether these 
are incorporated into the PtDA or a separate 
document/leaflet is developed should be discussed and 
carefully considered 
 
Table 2.2: Recommendations for developing and implementing a PtDA into the Bristol 
adult CF service 
 
Conclusion 
The findings demonstrate that current service provision for lung-transplant is 
broadly acceptable in this UK NHS-based adult CF service. However, there are some areas 
where improvements could be made, particularly around information provision, 
communication and accessibility. A PtDA tool could support such developments 
effectively, and patients, family and staff saw a wide range of benefits that could occur 
alongside the introduction of such a tool. Future development requires that a service-
specific PtDA is created with the aim of improving access to information that will enhance 
informed decision making, emotional support and promote greater involvement of patients 
and families in treatment decisions. If such is carefully developed, implemented and 








Braun, V., & Clarke, V. (2006). Using thematic analysis in psychology. Qualitative 
research in psychology, 3(2), 77-101.  
Coulter, A., Stilwell, D., Kryworuchko, J., Mullen, P. D., Ng, C. J., & van der Weijden, T. 
(2013). A systematic development process for patient decision aids. BMC medical 
informatics and decision making, 13(Suppl 2), S2.  
Dodge, J., Lewis, P., Stanton, M., & Wilsher, J. (2007). Cystic fibrosis mortality and 
survival in the UK: 1947–2003. European Respiratory Journal, 29(3), 522-526.  
Elwyn, G., Scholl, I., Tietbohl, C., Mann, M., Edwards, A. G., Clay, C., . . . Wexler, R. M. 
(2013). “Many miles to go…”: a systematic review of the implementation of 
patient decision support interventions into routine clinical practice. BMC medical 
informatics and decision making, 13(Suppl 2), S14.  
Francis, J. J., Johnston, M., Robertson, C., Glidewell, L., Entwistle, V., Eccles, M. P., & 
Grimshaw, J. M. (2010). What is an adequate sample size? Operationalising data 
saturation for theory-based interview studies. Psychology and Health, 25(10), 
1229-1245.  
Gale, N. K., Heath, G., Cameron, E., Rashid, S., & Redwood, S. (2013). Using the 
framework method for the analysis of qualitative data in multi-disciplinary health 
research. BMC medical research methodology, 13(1), 117.  
Glaser, B. G., & Strauss, A. L. (2009). The discovery of grounded theory: Strategies for 
qualitative research: Transaction publishers. 
Goldbeck, L., Fidika, A., Herle, M., & Quittner, A. L. (2014). Psychological interventions 
for individuals with cystic fibrosis and their families. Cochrane Database Syst Rev, 
6.  
Lansley, A. (2010). Equity and excellence: liberating the NHS. Department of Health, 
London.  
Mall, M. A. E., S. (2014). Cystic Fibrosis (M. A. Mall & S. Elborin Eds.). Wakefield, UK: 
European Respiratory Society. 
O'connor, A., Drake, E., Fiset, V., Graham, I., Laupacis, A., & Tugwell, P. (1998). The 
Ottawa patient decision aids. Effective clinical practice: ECP, 2(4), 163-170.  
O'Connor, A. M., Bennett, C. L., Stacey, D., Barry, M., Col, N. F., Eden, K. B., . . . 
Khangura, S. (2009). Decision aids for people facing health treatment or screening 
decisions. The Cochrane Library.  
Ritchie, J., Lewis, J., Nicholls, C. M., & Ormston, R. (2013). Qualitative research 
practice: A guide for social science students and researchers: Sage. 
 78 
Vandemheen, K. L., O'Connor, A., Bell, S. C., Freitag, A., Bye, P., Jeanneret, A., . . . 
Ryan, G. (2009). Randomized trial of a decision aid for patients with cystic fibrosis 
considering lung transplantation. American journal of respiratory and critical care 







University of Bath 




Main Research Project 
 
The Role of Health Anxiety in Mild Cognitive 
Impairment  
 





Academic Supervisor: Professor Paul Salkovskis, Clinical Psychology 
Doctoral Programme, University of Bath. Tel. 01225 384350  Email: 
p.m.salkovskis@bath.ac.uk  
 
External Supervisor: Dr Orazio Giuffrida, Consultant Clinical Psychologist, 
Lead Psychologist for Older People’s Services in Herefordshire, 2gether 
NHS Trust. Tel. 01432 842200 Email: orazio.giuffrida@nhs.net  
 
Date: June 2017 
Word Count: 5,295 
 







Mild Cognitive Impairment (MCI) is a diagnosis which describes the ‘gap’ 
between healthy ageing and the early stages of pathological cognitive decline (Yates, 
Clare, & Woods, 2013); that is, people who appear, on the basis of their cognitive 
functioning, to be showing ‘milder’ signs of the type of cognitive decline often seen in 
dementia, in some instances as a prodrome. 
 
Peterson et al’s (1999) original diagnostic criteria outlines MCI as follows: 1) 
subjective reports of cognitive decline; 2) evidence of objective cognitive impairments on 
neuropsychological testing; 3) cognitive complaints beyond what is expected for age; 4) 
otherwise intact activities of daily living (ADLs). However, as it stands, there is no 
universally agreed classification system, with around 16 in existence, each one varying in 
the degree to which they place emphasis on different criterion (Stephan, Brayne, McKeith, 
Bond, & Matthews, 2008). Divisions also exist relevant to the primary complaint 
(amnestic vs. non-amnestic) and the number of cognitive domains affected (single vs. 
multiple) (Yates et al., 2013), emphasising further the heterogeneity that this label holds. 
 
Whilst a proportion of individuals with MCI progress to a dementia, this is not 
universally the case with some experiencing stability of impairment or even improvements 
(Bowen et al., 1997; Kluger, Ferris, Golomb, Mittelman, & Reisberg, 1999). The number 
of individuals who develop dementia also varies significantly, with prevalence rates 
ranging from 6.6% - 35% (Artero et al., 2008; Wahlund, Pihlstrand, & Jönhagen, 2003), 
demonstrating that heterogeneity exists not only in diagnosis but also in outcomes 
according to context and sampling. 
 
With MCI becoming one of the most commonly delivered diagnoses in memory 
services  (Wahlund et al., 2003), this heterogeneity is not without controversy and a 
number of ethical dilemmas have been highlighted. These include how best to explain this 
label without causing unnecessary distress, as well as avoiding stigmatisation (McKinlay, 
Leathem, & Merrick, 2014; Werner & Korczyn, 2008).  
 
These ethical dilemmas are also central to the experience of individuals with MCI. 
Beard and Neary’s (2013) grounded theory approach found overarching themes of 
uncertainty relevant to the definition of MCI as well as the distinction between MCI as 
normal ageing vs. a dementia prodrome. They suggested that such ambiguity creates social 
and psychological tensions and that the fear of negative consequences associated with 
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dementia can cause a ‘courtesy stigma’. Government policies promoting earlier diagnosis 
have consequently been suggested to be at the detriment of emotional well-being 
(Gomersall et al., 2015; Le Couteur, 2013). What is more, with minimal to no evidence for 
the efficacy of interventions (Chandler, Parks, Marsiske, Rotblatt, & Smith, 2016; Cooper, 
Li, Lyketsos, & Livingston, 2013; Stott & Spector, 2011), the diagnosis is too often given 
with little or no support. 
 
Investigation of illness representations have found marked bimodal distributions 
on the consequences (i.e. effects of MCI) and coherence (i.e. understanding what MCI is) 
subscales  of the  IPQ-MCI (Lin, Gleason, & Heidrich, 2012). In addition, the three most 
frequently endorsed ( 50%) attributed causes of MCI were ageing, hereditary/genetic risk 
factor and abnormal changes in the brain. This study proposes that the discrepancy in 
attributions, understanding and predicted consequences of MCI, occurring within a context 
of uncertainty and ambiguity, warrants consideration of a possible role of Health Anxiety 
(HA). 
 
Increased levels of HA has been shown to be associated with a negative response 
to ambiguous health information (Rimes & Salkovskis, 2002) and neurological disease 
(Multiple Sclerosis; (Hayter, Salkovskis, Silber, & Morris, 2016) & Parkinson’s Disease; 
(Fixter, 2015). Salkovskis and Warwick’s cognitive model of HA (1986) proposes that 
attribution of health-related information to serious physical illness, produces and maintains 
a sense of current threat to health. The belief that one is developing a dementia has been 
suggested to produce an ongoing health threat in individuals with MCI (Suhr & Kinkela, 
2007b). Furthermore, this belief has also been found to be associated with perceived 
negative consequences of MCI (Galvin, Fu, Nguyen, Glasheen, & Scharff, 2008). 
 
A sense of threat has also been found to influence help seeking behaviours in MCI 
(Galvin et al., 2008), another parallel to Salkovskis and Warwick’s HA model. Avoidance 
of health professionals and/or friends/relatives with memory concerns, thought 
suppression, hypervigilant “symptom checking” and higher levels of treatment seeking 
behaviour have all been evidenced in individuals with MCI (Corner & Bond, 2004; 
Hodgson & Cutler, 2003; Suhr & Kinkela, 2007a); all of which are in line with the 
proposed role of safety seeking behaviours (Salkovskis, 1991) in HA. 
 
The role of HA in differing reactions to a diagnosis has been demonstrated within 
the context of long term physical health conditions, including patients with Relapse and 
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Remitting Multiple Sclerosis (RRMS) and Parkinson’s Disease (Fixter, 2015; Hayter et 
al., 2016). In both studies, a high HA group reported poorer quality of life (QoL) as 
compared to a low HA group and healthy controls, independent of level of disability. They 
also found that those with high HA were more likely to subjectively rate their performance 
on tests of cognitive function as poorer and attribute their performance on these tasks to 
their health condition, independent of objective performance. In spite of suggested 
associations between MCI and poor subjective ratings of cognitive performance (Werner, 
2003), health related worries (Wisocki, 1988) and QoL (Bárrios et al., 2013), the nature of 
these relationships are yet to be investigated.  
 
Consequently, this study aims to investigate the proposed relationship between HA 
and individuals’ experiences of MCI. Specifically, it is hypothesised that perceived QoL, 
subjective ratings of cognitive performance and attribution of cognitive performance to 
MCI will all be adversely impacted by high levels of HA, independent of level of 
objective impairment. In addition, the study also investigates the relationship between HA 
and illness representations in MCI; specifically, the consequences and causes domains of 




Two groups of participants were recruited: a group of older adults with a diagnosis 
of MCI (n = 45) and a normative sample of healthy controls without cognitive 
impairments (n = 17). Participant incentives were not provided.  
 
Potential participants for the MCI sample were identified by clinicians working in 
four NHS Memory Services across the South West regions. They were approached by the 
identifying clinician who provided them with a patient information sheet and obtained 
verbal consent for the lead researcher to contact them.  In addition, the ‘Join Dementia 
Research’ (JDR) register was also used as a recruitment tool for both samples. The JDR is 
a HRA endorsed online self-registration tool that enables volunteers with memory 
problems, carers of those with memory problems and healthy volunteers to register their 
interest in research. The lead researcher contacted potential participants via telephone or 























Figure 3.1: Flowchart of participant recruitment 
 
The MCI sample was subsequently split based upon their scores on the short form 
Health Anxiety Inventory (SHAI). This resulted in three groups for comparison; a high 
HA MCI group (HiHA), low HA MCI group (LoHA) and healthy control group (HC).  
 
Inclusion/Exclusion criteria  
For the MCI sample the following inclusion criteria were applied: 1) diagnosis of 
MCI; 2) aged 50 years; 3) English speaking. The latter two criteria were also applied to 
the HC sample with the addition of a score 26 on the Montreal Cognitive Assessment 
(MOCA; Nasreddine et al., 2005), which acted as a screening tool to confirm the absence 
of cognitive impairment.  
 
Exclusion criteria for all groups included neurological diagnoses (including a 
dementia), diagnosis of a significant mental health disorders (i.e. bipolar disorder, 
psychosis, chronic depression/anxiety disorder) and current substance dependence. 
Approached by NHS memory services (n = 72) 
Contacted via JDR (n = 46) 
Total n = 118 
 
Expressed interest (n = 60) 
 
Declined/unable to 
contact (n = 58) 
 
Ineligible 
(n = 4) 
 
Eligible participants 
(n = 56) 
 
Additional recruitment via 
word of mouth (n = 6)  
 
Total sample (n = 62) 
(MCI = 45; Health controls = 17) 
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Short version of the Health Anxiety Inventory (SHAI) 
A 14-item self-report questionnaire measuring general health-related anxiety. A cut 
off score of 18 indicates a clinical level of HA. The SHAI has good internal consistency 
(α = 0.89) and scores are not elevated significantly in individuals with a physical health 
problem (Salkovskis, Rimes, Warwick, & Clark, 2002), an important consideration when 
working with an ageing population.  
 
Illness Perception Questionnaire – Mild Cognitive Impairment (IPQ-MCI) 
A recent adaptation of the IPQ –R which is adapted for use with individuals with 
MCI (Lin et al., 2012). The original IPQ-R is designed to be adapted for use with various 
illness/threats to health and has reported good reliability (α = 0.67 – 0.81 across differing 
domains) and validity (Moss-Morris et al., 2002). This study utilises the consequences and 
causal domains of the IPQ-MCI in line with the central role of health-related attributions 
and catastrophising in the HA model (Salkovskis & Warwick, 1986). 
 
Objective measures of cognitive impairment 
A measure of new learning, the verbal paired associates subtest of the Wechsler 
Memory Scale 4
th
 edition (WMS-IV; Wechsler, 2009), was administered by the researcher 
according to standardised instructions. Although it is a primary subtest of the WMS-IV, 
the verbal paired associates subtest can be substituted for the California Verbal Learning 
Test 2
nd
 edition (CVLT-II), a list learning task, and as such its use should not interfere 
with clinical care. Performance on this test is likely to be in line with individuals’ 
subjective and objective impairments and has been shown to be useful in eliciting early 
deficits of dementia (Bondi, Salmon, & Kaszniak, 2009). 
 
A measure of cognitive function less commonly associated with MCI, the picture 
completion subtest of the Wechsler Adult Intelligence Scale 4
th
 edition (WAIS IV; 
Wechsler, 2008), was also administered. Scores on this test have been shown to remain 
high in patients with mild to moderate dementia (Logsdon, Teri, Williams, Vitiello, & 
Prinz, 1989); the assumption being that it should also remain relatively intact in 
individuals with MCI whose cognitive impairments are mild. 
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Subjective measures of cognitive performance 
Subjective performance is evaluated using a self-report measure in line with that 
used by Hayter et al (2016) & Fixter (2015). This 5-item Likert scale measures perceived 
performance compared to others and attribution of performance to MCI. 
 
Quality of Life – Alzheimer’s Disease scale (QOL-AD) 
A 13-item rating scale administered by an interviewer according to standard 
instructions. Each item is rated (poor – excellent) based upon participants’ responses. 
Although designed primarily for use with individuals with dementia, it is valid and reliable 
with individuals who cognitive function is mildly and moderately affected (Logsdon, 
Gibbons, McCurry, & Teri, 2002). 
 
Geriatric Anxiety Inventory (GAI) 
A 20-item self-report questionnaire measuring anxiety in older adults (Pachana et 
al., 2007). Use of a ‘yes-no’ format is suggested as valid for use with individuals with 
MCI.  A cut off score of 9 indicates clinical levels of anxiety. Internal consistency is high 
(α = 0.91). 
 
Short form of the Geriatric Depression Scale (GDS)  
A 15 item self-report questionnaire measuring depression in older adults 
(Yesavage et al., 1983). As with the GAI, its ‘yes-no’ format has been suggested to be 
reliable and valid in MCI. A cut of score of  5 indicates depression with 10 being 
indicative of severe depression. Internal consistency is high (α = 0.94). 
 
Bristol Activities of Daily Living Scale (BADLS) 
A 20 item proxy questionnaire assessing functional ability across various ADLs 
(Bucks, Ashworth, Wilcock, & Siegfried, 1996), used in this study as a measure of 
disability. It is generally completed by a close relative or friend. 
 
Procedure 
Ethical approval was obtained by the NHS Health Research Authority (ref: 
16/SC/0557) and subsequently by the University of Bath Psychology Ethics Committee 
(ref: 16-225). 
 
All eligible participants were contacted by the lead researcher via telephone or 
email. Participants were offered the choice of holding the appointment at their local 
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memory service, the University of Bath or their own home. Appointments were completed 
by the lead researcher or a research assistant working in one of the recruiting memory 
services.   
 
Written informed consent was obtained at the research appointment. It was made 
clear that participants were under no obligation to participate and had the right to 
withdraw at any time. Healthy controls completed the MOCA screening test first. One 
person was excluded on the basis of this score and their GP was contacted with their 
consent as per the study’s ethics procedure. Participants were then asked to complete the 
questionnaire pack (GAI, GDS, SHAI, IPQ-MCI), structured interview (QOL-AD), 
cognitive tests (order of administration varied across participants) and self-ratings of 
performance. The control group did not complete the IPQ-MCI or a self-rating of the 
attribution of task performance to MCI.  
 
All participants were asked to identify a close relative/friend to complete the 
BADLS. If the identified person was present at the appointment, then it was completed 
during this session. Otherwise the completed questionnaire was returned to the researcher 
by post or completed over the telephone at a later date.  
 
Statistical Analyses  
Power considerations 
According to calculations performed using G*Power based on a 2x3 ANOVA, to 
achieve power of 0.8 with alpha of 0.05 and a large effect size (in line with Hayter et al, 
2016), a sample size of 66 is necessary (i.e. 22 in each of the three groups).   
 
Missing data 
Six participants could not identify a close relative/friend who they felt comfortable 
asking to complete the BADLS; two from the HC group and four from the MCI group. As 
such six participants’ data could not be included in the BADLS analyses. 
 
Analysis 
Analysis was performed using SPSS version 24. The three groups (HiHA; LoHA; 
HC) were compared using ANOVAs (with ANCOVAs where appropriate) for group 
analyses. Where effects indicated need to control for severity of impairment the WMS IV 
score was used as co-variate. Within subject’s analyses utilised mixed model’s ANOVAs, 
with simple main effect analyses used to interpret any significant interactions. Planned 
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comparisons were made. Where possible Least Significant-Difference (LSD) was used. If 
Levene’s test for homogeneity of variance was significant, Dunnett’s T3 test was used. 
Cohen’s d was used to calculate effect size. Chi-squared analyses were used for 
categorical variables to investigate group differences. The alpha level was set at p = 0.05 





As can be seen in Table 3.1, the MCI sample consisted of 16 females (35.5%) and 
29 males (64.5%) with a mean age of 75.3 years (range 57 – 92; SD= 7.66). One 
participant identified themselves as White European; all other participants identified 
themselves as White British. Participants had a mean number of years in education of 13.1 
years (range 9 – 23 years; SD = 3.67). Participants had a mean number of identified health 
problems of 1.4 (range 0 – 8; SD = 1.78). 
 
The healthy control sample consisted of 8 females (47%) and 9 males (53%) with a 
mean age of 73.4 years (range 62 – 90; SD = 7.51). All participants identified themselves 
as White British. Participants had a mean number of years in education of 14.9 years 
(range 9 – 21; SD = 3.78). Participants had a mean number of identified health problems 
of 2.4 (range 0 – 11; SD = 2.59). 
 
Comparison of the three groups showed no significant differences in age, (F(2, 51) = 
3.04, p = 0.056); gender, (2 (2) = 0.70, p > 0.05) and years in education, (F(2, 51) = 0.97, p > 
0.05). Consequently, samples were comparable on demographic characteristics. 
 
Patient characteristics 
The total MCI sample had a mean score of 8.51 (SD = 6.48) on the SHAI. For 
main analyses, HiHA was defined as a score of  9 and LoHA was defined as a score of  
6. These cut-off values were devised through inspection of the distribution so that the 
point difference between groups was at least one standard error of the SHAI (SE = 1.12; 
(Salkovskis et al., 2002). This resulted in the removal of eight participants’ data. This 
method was used instead of clinical cut-off values for the SHAI as insufficient participants 
scored in the high health anxiety range. This resulted in 18 participants in the HiHA group 
and 19 participants in the LoHA group. Participants who fell between these two cut offs 
were excluded from all other analyses. 17 healthy controls had a mean score of 8.58 on the 
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SHAI (SD = 6.09). Three participants (7%) in the total MCI sample and three healthy 
controls (18%) scored above clinical cut off on the SHAI. 
 
There were no significant differences in general anxiety across groups as measured 
by the GAI (F(2, 51) = 3.16 p = 0.051). Groups did differ significantly in their scores on the 
GDS as a measure of depression (F(2, 51) = 4.19, p < 0.05). Multiple comparisons (LSD) 
indicated that the HiHA group scored significantly higher on the GDS as compared with 
LoHA and controls (p < 0.05), indicating lower mood in the HiHA group. There was no 
significant difference between the control group and the LoHA group (p > 0.05).  
 
Cognitive tasks 
A one-way ANOVA comparing the three groups (HiHA, LoHA, HC) on the verbal 
paired associates subtest of the WMS IV showed a significant main effect of group (F(2, 51) 
= 14.08, p < 0.05). Multiple comparisons (LSD) indicated that both MCI groups (HiHA, 
LoHA) were not significantly different from one another (p > 0.05) but were significantly 
different from controls (p < 0.05), such that controls performed significantly higher than 
the MCI groups. 
 
A one-way ANOVA comparing the three groups on the picture completion subtest 
of the WAIS IV also showed a significant effect of group, (F(2, 51) = 3.19, p < 0.05). 
Multiple comparisons (LSD) indicated that both MCI groups (HiHA, LoHA) were not 
significantly different from one another (p > 0.05). Those with low health anxiety were 
significantly different from controls (p < 0.05) as expected. The high health anxiety group 
were not significantly different from controls (p > 0.05). 
 
Functional impairment 
In addition to objective cognitive impairment, functional impairment was also 
analysed given its role in the definition of MCI. A one-way ANOVA showed a main effect 
of group (F(2, 45) = 3.73, p < 0.05). Multiple comparisons (LSD) indicated that both MCI 
groups (HiHA, LoHA) were not significantly different from one another (p > 0.05). Those 
with low health anxiety were significantly different from controls (p < 0.05) as expected. 
However, the HiHA group were not significantly different from controls (p > 0.05). Group 
means indicated good functionality in all three groups (LoHA = 2.94; HiHA = 3.71; HC = 




Key Outcome Variables 
Quality of Life 
In the first co-primary analysis, the three groups were compared on QoL, as 
measured by the QoL-AD. A one-way ANOVA showed a main effect of group on QoL-
AD scores (F(2, 51) = 7.15, p < 0.05). Multiple comparisons (LSD) indicated that poorer 
QoL was a feature of the HiHA group only, who reported significantly lower scores on the 
QoL-AD than the LoHA group (p = 0.001) and healthy controls (p < 0.05). The LoHA and 
control group did not differ significantly (p > 0.05) (see Table 3.2). There was a large 
effect size (d = 1.29). 
 
As planned, an ANCOVA was carried out comparing the three groups, controlling 
for level of cognitive impairment, as measured by verbal paired associated subtest of the 
WMS IV. The main effect of group was substantially unchanged (F(2, 50) = 7.31, p < 0.05). 




In the second co-primary analysis, perceived task performance was analysed 
utilising a 3 (HiHA, LoHA, HC) by 2 (performance ratings on WAIS & WMS) mixed 
model ANOVA. A significant main effect of task type on perceived performance was 
found (F(1, 51) = 10.50, p < 0.05), such that participants rated their performance on the 
WMS IV subscale as poorer than that of the WAIS IV. A significant main effect of group 
on perceived performance was also found (F(2, 51) = 12.11, p < 0.05), such that healthy 
controls rated their performance as better than both MCI groups. The interaction between 
group and perceived performance was not significant (F(2, 51) = 0.581, p > 0.05). As such, 
no further analyses were conducted. 
 
Attribution of performance to MCI 
In addition to perceived performance, perceived attributions of task performance to 
MCI was also analysed via a 2 (HiHA, LoHA) by 2 (attribution ratings on WAIS & 
WMS) mixed model ANOVA. A significant main effect of task type on perceived 
attribution was found (F(1, 35) = 17.27, p < 0.05), such that participants attributed their 
performance on the WMS IV to their MCI more than their performance on the WAIS IV. 
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Table 3.1: Means (SDs) of sample and patient characteristics, cognitive tasks and measure of functional impairment 
 HC (n = 17) MCI (Total) (n = 45) MCI (LoHA) (n = 19) MCI (HiHA) (n = 18) 
Sample Characteristics Mean (SD) Mean (SD Mean (SD) Mean (SD) 
Age 73.41 (7.52) 75.33 (7.67) 77.63 (6.18) 71.89 (8.26) 
Gender 47% female 
53% male 
35.5% female 





Years in Education 14.94 (3.78) 13.18 (3.67) 13.32 (3.42) 13.50 (4.13) 
Patient Characteristics     
SHAI 8.59 (6.09) 8.51 (6.48) 3.42 (1.98) 14.22 (6.39) 
GAI 2.76 (3.65) 3.49 (4.98) 1.74 (3.49) 5.50 (6.34) 
GDS 2.65 (3.28) 3.64 (2.81) 2.37 (2.01) 4.89 (3.22) 
Cognitive Tasks     
Paired associates (WMS IV) 29.76 (6.44) 17.38 (8.97) 14.73 (7.47) 20.22 (11.00) 
Picture completion (WAIS IV) 12.12 (4.36) 9.69 (3.86) 8.68 (3.79) 10.39 (4.07) 
Functional Impairment     
BADLS 0.27 (0.70) 3.62 (4.20) 2.94 (3.98) 3.71 (4.79) 
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There was no significant effect of group on perceived attribution (F(1, 35) = 1.31, p > 
0.05). The interaction between group and perceived performance was also not significant 
(F(1, 35) = 1.05, p > 0.05).  
 
 HC (n = 17) MCI (Total) 
(n = 45) 
MCI (LoHA) 
(n = 19) 
MCI (HiHA) 
(n = 18) 
 Mean (SD) Mean (SD Mean (SD) Mean (SD) 
QoL 41.00 (7.53) 38.20 (6.27) 41.89 (5.75) 34.67 (5.44) 
Self-rating: Perceived 
Performance WMS 
2.82 (0.53) 3.60 (0.81) 3.68 (0.67) 3.72 (0.83) 
Self-rating: Perceived 
Performance WAIS 
2.59 (0.87) 3.07 (0.69) 3.11 (0.74) 3.22 (0.55) 
Self-rating: Attribution 
to MCI WMS 
N/A 4.13 (0.69) 4.11 (0.81) 4.17 (0.62) 
Self-rating: Attribution 
to MCI WAIS 
N/A 3.60 (0.69) 3.37 (0.76) 3.72 (0.57) 
Table 3.2: Means (SDs) for the key outcome variables across groups 
 
Illness perceptions 
Secondary analyses investigated the two MCI groups’ (HiHA & LoHA) illness 
perceptions, as measured by the consequences and causes domains of the IPQ-MCI (Table 
3.3). A one-way ANOVA was used to analyse the consequences domain. It showed a main 
effect of group (F(1, 35) = 13.44, p < 0.05), such that the HiHA group scored significantly 
higher on the consequences domain; a higher score being indicative of greater perceived 
consequences of MCI. 
 
Causal attributions were clustered according to the four causal factors identified by 
Moss-Morris et al (2002) with a fifth factor added, comprising of the additional causal 
factors introduced in the development of the IPQ-MCI (Lin et al., 2012). Due to differing 
numbers of items in each factor, means for each causal factor were calculated such that the 
groups were comparable. A 2 (HiHA, LoHA) by 5 (Causal factors 1 – 5) mixed model 
ANOVA found no significant effect of causal factor (F(3, 104) = 1.35, p > 0.05). A 
significant effect of group was found (F(1, 35) = 15.74, p < 0.05), such that more causal 
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attributions overall were made by the HiHA group. There was no significant interaction 
(F(3, 104) = 1.59, p > 0.05). 
 
 MCI (Total)  
(n = 45) 
MCI (LoHA)  
(n = 19) 
MCI (HiHA)  
(n = 18) 
 Mean (SD Mean (SD) Mean (SD) 
IPQ-MCI Consequences 28.47 (5.78) 25.37 (6.00) 31.56 (4.00) 
IPQ –MCI Causes: Psychological 
attributions 
12.84 (5.20) 10.79 (4.08) 15.00 (5.11) 
IPQ –MCI Causes: Risk Factors 15.47 (4.95) 13.79 (4.12) 16.83 (4.62) 
IPQ –MCI Causes: Immunity 5.80 (2.46) 4.58 (1.64) 7.22 (2.44) 
IPQ –MCI Causes: Accident or 
chance 
4.31 (1.70) 3.58 (1.43) 5.00 (1.75) 
IPQ –MCI Causes: MCI factors  14.98 (4.92) 11.84 (3.78) 18.17 (3.60) 
Table 3.3: Means (SDs) for illness perceptions (consequences & causes) across groups 
 
Stepwise Regression Analyses 
In a tertiary analysis, stepwise linear regressions were used to evaluate the relative 
contribution of psychological factors (SHAI, GAI and GDS) and level of impairment 
(WMS IV subtest) in predicting QoL, perceived task performance and illness perceptions 
(consequences domain) across the entire MCI group (Table 3.4). Collinearity statistics and 
diagnostics were conducted with no identified concerns.  
 
For QoL, two variables entered the model. The first variable to enter was 
depression (GDS), accounting for 38.8% of the variance in scores on the QoL-AD 
(adjusted R
2 
= 0.388,  = -0.69, p < 0.001). The second variable entered was the WMS IV 
subtest (adjusted total R
2 
= 0.511,  = -0.36, p = 0.001). R2 change attributable to the 
WMS IV was 0.131. For perceived performance, one variable entered the model. Actual 
performance on WMS IV accounted for 17.1% of the variance in perceived performance 
ratings on WMS IV (adjusted R
2 
= 0.171,  = -0.43, p < 0.05).   
 
Finally, for illness perceptions, one variable entered the model. General anxiety 
(GAI) accounted for 16% of the variance in scores on the consequences domain of the 
IPQ-MCI (adjusted R
2 
= 0.16,  = 0.42, p < 0.05).  
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 B SE B  
QoL    
Step 1    
Constant 43.35 1.20  
GDS -1.41 0.26 -0.63 
Step 2    
Constant 48.31 1.80  
GDS -1.51 0.24 -0.70 
WMS IV subscale -0.26 0.08 -0.37 
Self-ratings of task 
performance 
   
Step 1    
Constant 4.28 0.24  
WMS IV subscale -0.04 0.01 -0.44 
Illness perceptions 
(consequences) 
   
Step 1    
Constant 26.75 0.97  
GAI 0.49 0.16 0.42 
Table 3.4: Stepwise regression results for variables predicting QoL, perceived 
performance and illness perceptions (consequences) 
 
Discussion  
The study evaluated the impact of health anxiety in QoL, perceived performance 
on cognitive tasks, attribution of performance to MCI and illness perceptions. As 
predicted, both HiHA & LoHA groups showed more cognitive impairment than controls 
but did not differ from each other. High HA was associated with poorer QoL as predicted. 
However, contrary to prediction it was not related to perceived impairment or attribution 
of MCI to task performance, nor was it related to health beliefs. In additional analyses, 
depression and level of cognitive impairment were identified as significant predictors of 
QoL. Level of impairment was also a significant predictor of perceived performance. 
Generalised anxiety was a significant predictor of health beliefs.  
 
Given that individuals with MCI by definition have experienced a decline in their 
cognitive abilities, a reduction in QoL is understandable. However, this effect was found 
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to be related to an individual’s level of HA and was not eradicated when co-varying for 
actual level of cognitive impairment. This is consistent with previous studies which report 
an association between QoL and MCI irrespective of degree of impairment (Banerjee et 
al., 2009; Bárrios et al., 2013). Furthermore, the results are also in line with Hayter et al 
(2016) and Fixter (2015) who found a similar pattern of results in patients with RRMS and 
PD such that higher levels of HA were associated with significant reductions in QoL. 
 
However, whilst the present study supports the link between HA and QoL, it 
differs in terms of the finding from exploratory analyses which suggested that for MCI 
there is an association between the individual’s degree of memory impairment and 
depression. Although unexpected, this finding highlights a potentially important link with 
depression and cognitive impairment in individuals with MCI, perhaps associated with an 
individual’s ‘insight’ into their difficulties. The suggested role of ‘insight’ was also 
supported by exploratory analyses which found perceived impairment to be significantly 
associated with actual level of impairment in the MCI sample such that participants rated 
their performance as poorer if their level of their impairment was more severe. The role of 
depression, whilst not predicted in this particular study, is in line with the suggestion that 
depression commonly occurs in individuals with MCI (Barnes, Alexopoulos, Lopez, 
Williamson, & Yaffe, 2006; Bruce et al., 2008) and supports early evidence of a 
relationship between depressive symptoms and health-related QoL in patients with 
cognitive impairments (Pusswald et al., 2016).  Depression and cognitive impairment as 
significant factors in QoL may be attributable to insight, such that with an awareness of 
their declining cognitive function, comes a decline in mood. Conversely, it is worth 
considering whether this could also be representative of a so-called ‘depressive 
psuedodementia’ (Kiloh, 1961) sample; an important distinction worthy of further 
investigation given the suggestion that cognitive impairment in ‘depressive 
psuedodementia’ may be reversible secondary to treatment for depression (Muangpaisan, 
Petcharat, & Srinonprasert, 2012). 
 
The present study did not replicate Hayter et al (2016) and Fixter’s (2015) findings 
with regards to a role of HA in subjective ratings of cognitive performance, instead finding 
that perceived performance on cognitive tasks was associated with objective levels of 
cognitive impairment, suggesting it was linked to insight. However, it is inconsistent with 
research which suggests that individuals with MCI, whilst accurate in reporting depressive 
symptoms and QoL, have a tendency to under-report their level of impairment (Arlt et al., 
2008). 
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The present study also did not replicate the relationship between HA and 
attribution of task performance to their health condition as per Hayter et al (2016) and 
Fixter (2015). However, it did find a significant effect of group on causal attributions of 
IPQ-MCI such that individuals with HiHA were more likely to make attributions to their 
health condition. This is supportive of the role of increased health-related attributions in 
HA in Salkovskis and Warwick’s model (1986). In the absence of a significant interaction, 
it suggests a general increased likelihood to make attributions in MCI in the absence of 
specificity of type of attribution made. 
 
Limitations 
The study is limited by its’ sample size such that it did achieve the planned level of 
power. However, the effect size of the nonsignificant effect of HA on perceived cognitive 
performance was very small (d = 0.05) and as such it is likely that this represents a true 
negative finding. The small sample size did limit the extent of the difference between the 
LoHA and HiHA groups, although the minimum of one standard error difference was 
achieved. The study was also unable to use the clinical cut offs for the SHAI due to very 
limited numbers of the MCI sample scoring in the clinical range for HA (7%) and it is 
possible that inclusion of greater numbers would have yielded a broader range of SHAI 
scores allowing for the use of clinical cut offs, thus creating a larger gap between LoHA 
and HiHA groups. Comparison with SHAI means in Fixter (2015) and Hayter et al (2016), 
demonstrate lower levels of HA in the MCI sample and it is possible that a sample with 
higher levels of HA may have strengthened the relationship with QoL. In addition, it is 
also worth noting that greater numbers of MCI participants (27%) scored above the 
clinical cut off for depression, perhaps suggesting a greater prevalence of depression in 
MCI.  
 
The study also utilised a heterogeneous MCI sample with regards to type and 
severity of cognitive impairment as opposed to classifying the sample according to 
primary impairment (e.g. amnestic vs. non-amnestic). Whilst this is likely to be 
representative of the population receiving this diagnosis in clinical practice, it is worth 
considering within the context of the choice of the WMS IV as the primary measure of 
objective cognitive impairment. Cognitive difficulties captured by the WMS IV are likely 
to be more closely associated with those presenting with an amnestic MCI profile, given 
that this selected subscale is primarily a measure of short-term memory, specifically new 
learning. In addition, the role of explicit feedback in the administration of the paired 
associates subscale should also be considered given that results suggested good insight in 
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our sample contrary to other studies (Arlt et al., 2008). Whilst feedback is included in the 
paired associates subscale to assess new learning, it may have inadvertently aided 
participants in their ability to gauge their cognitive performance and replication of the 
study with a more ambiguous cognitive task may yield different results. 
 
The use of stepwise regression as opposed to other forms of regression analyses 
may also be questioned following concerns regarding the limitations of using a stepwise 
approach. These concerns include the role of the variable selection method and multiple 
comparisons. Holding these limitations in mind, it is possible that use of a different 
regression analyses may have yielded different results. 
 
Future research 
Future research would benefit from further investigation into the mediating role of 
depression and cognitive impairment in QoL in MCI, including a qualitative exploration 
of the experience of QoL in MCI. More detailed investigation at the level of the individual 
items on the QoL-AD measure may also pose some interesting questions to be explored 
further. A longitudinal approach would also allow for investigation of possible causality. 
This is particularly pertinent giving the ongoing debate surrounding the relationship 
between late-life depression and cognitive impairment, including the possibility of late-
onset depressive symptoms being indicative of an increased likelihood of progression of 
cognitive impairments to a dementia (Palmer et al., 2007) with some going as far as to 
suggest that depression, MCI and dementia may in fact lie on a clinical continuum (Panza 
et al., 2010). Investigation of the role of insight into one’s cognitive impairments and its’ 
potential relationship with psychological distress would also be beneficial.  
 
Replication with a large sample would also be warranted to determine whether our 
findings are reflective of the true nature of psychological difficulties experienced in this 
population, such that depression may be a more pertinent issue for this population. 
Relatedly, looking at the prevalence rates of different psychological difficulties in an MCI 
population would be beneficial, particularly given recent suggestions that MCI is 
becoming primarily a “psychosocial issue” (Verhey & de Vugt, 2013). Clinical levels of 
HA were notably low in our sample (7%) and it would be worthy of investigation as to 
whether this was representative of the prevalence rates in this population or was instead 





The findings of this study have identified significant roles for HA and depression 
in QoL of individuals with MCI. As such, clinicians would benefit from the use of routine 
screening tools for psychological distress, particularly depression and health anxiety.  
 
The identified role of depression and cognitive impairment in mediating QoL in MCI has 
important clinical implications, particularly given evidence suggesting that depression 
may be an early risk factor for progression to dementia (Palmer et al., 2007). Better 
understanding the relationship between psychological factors in this population is 
particularly pertinent given that all too often many individuals are left with an ambiguous 
diagnosis and little to no professional support. As such, further investigation of the 
efficacy of psychological support, e.g. cognitive-behavioural treatments, in clinical 
practice would be warranted. The effectiveness of such interventions in practice could be 
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Mild cognitive impairment (MCI) is a common yet controversial diagnosis with 
marked heterogeneity in its’ diagnostic criteria and clinical outcomes. This heterogeneity 
brings with it uncertainty and ambiguity for both the clinicians working in memory 
services as well as the individuals who receive this label. This study aims to investigate 
the extent and role of health anxiety in individuals’ experiences of MCI, evaluating the 




Forty-five individuals with MCI completed questionnaires assessing HA, QoL, 
mood, functional ability and health beliefs. They also completed two cognitive tasks 
followed by self-ratings of perceived performance and attribution of their performance to 
MCI. Groups were compared based on their level of HA (low vs. high) and to a sample of 
non-impaired controls (n = 17). Participants in the MCI sample were divided into high HA 
and low HA groups according to their scores on the Short version of the Health Anxiety 
Inventory (SHAI) for subsequent analyses. 
 
Results 
As predicted, both the high heatlth anxiety MCI group (HiHA) & the low health 
anxiety MCI group (LoHA) showed more cognitive impairment than controls but did not 
differ from each other. The high HA group reported significantly reduced QoL as 
compared to the low HA group and healthy controls. No significant effect of HA was 
found on perceived performance or attribution of performance to MCI. In further 
exploratory analyses, depression and level of cognitive impairment were identified as 
significant predictors of QoL. Level of impairment was also a significant predictor of 
perceived performance. Generalised anxiety was a significant predictor of health beliefs.  
 
Whilst the present study supports the link between HA and QoL as per previous 
research in Relapsing and Remitting Multiple Sclerosis and Parkinson’s Disease, it differs 
in terms of the finding from exploratory analyses which suggested that for MCI at least 
some of these effects may be mediated by the individual’s degree of memory impairment 
and depression. Although unexpected, this finding highlights a potentially important link 
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with depression and cognitive impairment in individuals with MCI, perhaps mediated by 
an individual’s ‘insight’ into their difficulties. 
 
Implications for Research 
Future research would benefit from further investigation into the mediating role of 
depression and cognitive impairment in QoL in MCI including: a qualitative exploration 
of the experience of QoL in MCI; investigation at the level of the individual items on the 
QoL measure (QoL-AD); and a longitudinal approach to allow for investigation of 
possible causality/directionality in the relationship between depression and QoL in MCI.  
 
Replication with a large sample would also be warranted to determine whether our 
findings are reflective of the true nature of psychological difficulties experienced in this 
population, such that depression may be a more pertinent issue for this population. 
Relatedly, looking at the prevalence rates of different psychological difficulties in an MCI 
population would be beneficial 
 
Clinical Implications 
 Given the identified significant roles for HA and depression in QoL of individuals 
with MCI, clinicians would benefit from the use of routine screening tools for 
psychological distress, particularly depression and health anxiety. Better understanding the 
relationship between psychological factors in this population is particularly pertinent given 
that all too often many individuals are left with an ambiguous diagnosis and little to no 
professional support. As such, further investigation of the efficacy of psychological 




Connecting Narrative  
Whilst conducted across different fields, my research has primarily focused on 
achieving a greater understanding of the experiences of individuals facing psychological 
difficulties with the aim of guiding best clinical practice whilst also making a valuable 
contribution to the evidence base. I have conducted a critical review of the literature to 
gain an understanding of the role of non-fear emotions, specifically guilt and shame, in the 
development and maintenance of PTSD in those individuals who are traumatised by their 
own actions; gained clinician, patient and carer perspectives in order to understand how 
best to support patients with the complex decision-making process surrounding whether or 
not to undergo lung transplantation in Cystic Fibrosis (CF); and investigated whether 
greater consideration of health anxiety (HA) in older adults with Mild Cognitive 
Impairment (MCI) would enable us to better understand the experiences of those 
individuals who receive this diagnosis. Completing this research has involved consulting 
relevant legislation and policies, critically reviewing relevant literature, involving service 
users in the design and implementation of research, and conducting both qualitative and 
quantitative research methodology across NHS-based services. 
 
Critical Review of the Literature 
 As with all of my research projects, the topic for my literature review arose from a 
pre-existing interest in posttraumatic stress disorder (PTSD). As an undergraduate I had 
completed my dissertation investigating contextual integration in information processing 
in PTSD and psychosis. I recall how at that time, I became fascinated with Ehlers and 
Clark’s cognitive model of PTSD (2000) and was keen to further develop my 
understanding of the mechanisms of PTSD development and maintenance throughout 
training. This fascination was rekindled by Martina Mueller, who facilitated our PTSD 
teaching in our first year of the doctoral programme. Martina spoke of the many 
dimensions of PTSD, beyond that of the well-known fear-based model. This began to 
make me wonder about what the mechanisms may be in the development and maintenance 
of PTSD when different emotions are involved. Guilt, and particularly shame, are 
emotions that I also hold a particular interest in, given my experience of how powerful 
these emotions can be in therapy; for example, making it difficult for people to fully share 
the details of their experiences for fear of being judged. This felt particularly pertinent in 
those individuals who may in fact be judged because of the nature of their trauma, when 
they are traumatised by their own actions. This was something else that Martina had 
touched upon in our teaching and I again found myself keen to know more. 
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 In addition to my previous research experience, my interest in this field also 
stemmed from personal experience. My fiancée is in the military and I have consequently 
developed an enthusiasm for the promotion of mental health support in military personnel 
and their loved ones. As an area where a substantial amount of stigma continues to exist, it 
felt valuable to conduct research in this field. Initially I had planned to explore the 
potential of conducting a main research project in the military; however, when my fiancée 
was told he was being sent to Afghanistan for 9 months, I decided this now felt too 
personal. As such, bringing this interest into my literature review felt like a more 
comfortable option. 
 
 From the beginning of the literature review, I quickly realised how I had 
underestimated the amount of time that would be involved. Having carefully defined my 
search terms, I felt a little shocked to have over 600 results, although I was also thankful 
that it was not more, knowing how others in my cohort had fell into the thousands. As I 
made my way through the literature, I found myself becoming increasingly enthusiastic as 
I discovered more and more that I didn’t know. My supervisor, Ailsa Russell, was helpful 
at assisting me in keeping my focus and ensuring that the review question was both clearly 
defined and appropriately focused so that the review did not become too all-encompassing 
and lose its’ empirical and heuristic value. We discussed the best means of synthesising 
what I had found, including how to analyse the information within the framework of 
available cognitive models as opposed to simply describing the information. Completing 
this review has certainly been a learning curve for me, I definitely feel my skills at 
searching for, synthesising, and critiquing empirical evidence have improved as a result of 
this process. 
 
Service Improvement Project 
 Another of my pre-training interests was in clinical health, being one of the many 
things that attracted me to the Bath course when applying. As such, I was keen that one of 
my projects was in this area. My service improvement project (SIP) arose following the 
research fair, after I contacted a number of research supervisors who had presented 
research areas in clinical health. Initially, I had hoped to complete my project in a 
paediatric service; however, following a discussion with Samantha Phillips, the Clinical 
Psychologist in the Cystic Fibrosis service, who provided me with some background 
literature relevant to supporting lung transplant decisions in CF, I found myself intrigued 
to learn more. 
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 Prior to starting training, my research experience had solely been using 
quantitative methodology, and I was eager to gain some experience in the qualitative field. 
Samantha and I discussed this as we began to shape the project together finding a way to 
incorporate the service need as well as my training needs and interests. Service user 
involvement in research, particularly at the service improvement level, is something I feel 
strongly about and as such I was keen to hear directly from patients in considering how 
best to shape the service to meet their needs. Having discussed this with Samantha, whilst 
she was happy for this to form part of the project, she also suggested we broaden the 
project to also include clinician perspectives due to a limited sample size. Being a 
sensitive topic for adults with CF, the service felt strongly about who they should invite to 
take part. Consequently, we agreed upon a clinician focus group alongside interviews open 
to patients and their significant others in the hope this would give us a good sample size. 
 
 Facilitating the focus group was something which I felt apprehensive about, 
finding public speaking and presentations to be anxiety-provoking. However, I was 
pleasantly surprised to find that not only did it run smoothly but there was clearly a wealth 
of data arising from the conversations the staff were having. Conducting the interviews 
was equally valuable and I remember feeling humbled by the conversations I had with the 
patients and their families, as it provided me with a stark reminder of the privilege of 
working in this role and the value that research can bring to directly improving patient 
experience. 
 
 Thematic analysis was unfamiliar and once again I found I underestimated the time 
and energy involved in this process. At this stage my internal supervisor, Liz Marks, was a 
considerable support agreeing to hold regular and lengthy meetings were we reviewed, re-
reviewed and re-reviewed once more the coding and themes whilst navigating our way 
through what was a relatively novel field for us both. During this process I learnt the 
nuances of thematic analysis, including whether I was working from an inductive or 
deductive position, and discovered how the reputation that qualitative research has as the 
‘easy option’ could not be further from the truth.  
 
Main Research Project 
 Having previously worked as an Assistant Psychologist in a memory service for 
older adults, I had already been party to a number of debates between clinicians in the 
service regarding how best to understand and navigate the relatively recent but 
increasingly common diagnosis of Mild Cognitive Impairment (MCI). It had always been 
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a label I had felt some unease at giving, and I had been curious to understand the very 
different receptions that it could receive from the people to whom I was giving this 
feedback. To begin with I had considered the way in which I was delivering this 
information but soon I came to realise that the same words could be received in very 
different ways. Consequently, when Paul Salkovskis broached the possible role of health 
anxiety (HA) in MCI in our first year HA teaching, it was a research question which 
immediately fit with the questions I had already been posing. 
 
 In discussing the research design, Paul very helpfully shared with me some 
previous research which had looked at a similar role of HA in other neurological 
conditions; namely Multiple Sclerosis (MS) and Parkinson’s disease (PD). Reading these 
studies alongside a review of the literature relevant to MCI, I was convinced of the 
heuristic value that this research could hold and felt excited at the prospect of conducting 
such beneficial research in a field that I already knew first hand could have very real 
clinical implications in the services working with these individuals. 
 
 Sadly, this excitement temporarily diminished as I navigated my way through what 
felt like a never-ending climb up a mountain of NHS ethics. Having never completed an 
IRAS form before, the endless pages of questions felt like an uphill struggle at times. 
Combined with a change in the HRA procedures amidst this process as well as navigating 
two Research and Development (R&D) ethics procedures too, there were certainly times 
when I questioned whether this was all worth it. However, as I emerged from the ethics 
battle a conqueror my excitement and passion for the research quickly returned.  
 
 Due to the nature of my research measures, my research meant that face to face 
appointments were the only option. This was a huge source of frustration at times when 
completing research as part of a doctoral training course that already has such significant 
time pressures on you. I was extremely lucky to have the support of my external 
supervisor, Orazio Giuffrida’s Assistant Psychologist, Chloe, who supported me during 
the recruitment and data collection stages of the research. In addition, working with Chloe 
also provided me with some valuable supervisory experience. Whilst my frustration was 
there, meeting with the participants face to face also became a huge driving force to keep 
me motivated to continue on as research fatigue set in. The process provided me with 
opportunity after opportunity to meet such kind and accommodating participants who 
received my research with such enthusiasm and gratitude that I felt compelled to work 
through the stress. 
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 I am enormously grateful for Paul’s support and guidance during the navigation of 
statistical analyses, booking regular meetings into his already full diary to help me remain 
on the right track. The primary statistical analyses I used were familiar to me having 
completed ANOVAs and ANCOVAs in my undergraduate research and this certainly 
helped, not being particularly fluent in the art of statistical analyses or SPSS. Seeing the 
hard work come together in the interpretation of and reflection on the results brought with 
it a sense of achievement and I found myself invested in my research and keen to increase 
my numbers that bit further in order to put forward for publication at a later date. 
 
Case Studies 
 Completing a case study on each of my four core placements and my first elective 
placement has been a hugely valuable experience in reflecting on both the professional 
role of therapy, as well as the personal impact that working with individuals with 
psychological difficulties can have on the training experience and personal development. 
Whilst a daunting process, I always commented on how I found the process of writing up a 
case study to be somewhat therapeutic for me as it brought together the work that we had 
done and was a means of keeping me in touch with the evidence-base and the its’ role in 
guiding our work with individuals, being the foundation of the therapeutic work that we 
do. 
 
However, writing the case studies was not without its challenges. Ensuring that the 
case studies met the requirements of the course, particularly the BABCP requirements, 
could at times feel like you were slightly fitting a person into a therapy mould rather than 
being truly guided by their experiences in developing a collaborative formulation. In this 
way, they also emphasised the delicate balancing act that comes with ensuring that you 
work with the individual formulation and experience as well as the evidence-base. As a 
result of the BABCP requirements, I have finished with all five of my case studies being 
in the field of cognitive-behavioural approaches and whilst I feel each one was valuable 
and enjoyed writing them, I would have liked to have had a case study written from a 
different perspective. I have been able to address this somewhat in presenting an 
integrative case study which involves not only transdiagnostic elements of CBT but also 
third-wave and compassion-focused approaches. I also extended my case study portfolio 
by writing up a group case study on my elective as a change from the individual case 
studies from my core placements. 
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 Completing case studies also highlighted to me the importance of using routine 
outcome measures in your work, both as an evaluative tool as well as a therapeutic one. In 
the context of working in services where routine outcome measures were not the norm, as 
well as working with individuals for whom it was important that they held meaning and 
were comprehendible (for example, having to create idiosyncratic measures on my 
learning disabilities placement), this was a challenge at times and I sometimes felt 
frustrated. However, on reflection I can now see the benefit of their use and have already 
discussed on my current placement the possibility of introducing routine outcome 
measures as a means of service improvement alongside aiding clinicians in evaluation of 
their work. 
 
Future Research Plans 
 After coming into training with minimal research skills as compared with my 
clinical experience and with little enthusiasm for working in a research environment, my 
research experiences have shifted this perspective. I can now see more clearly the value of 
being involved in research and the crucial role it has in our profession. I am already using 
the research skills I have developed on my final placement, working alongside my 
supervisor and the team manager to explore the introduction of outcome measures into the 
service, as well as discussing with a colleague who is also involved in the Thrive project in 
schools how they could evaluate the fantastic work that they are doing to disseminate this 
message more widely.  
 
Consequently, I now feel confident that my research career will continue (although 
perhaps completing fewer projects at any one given time!). I feel particularly passionate 
about the relationship between research and clinical practice and the role that this can have 
in shaping service improvement. I also hugely valued the experience of completing 
qualitative research as a means of involving service users more in service development 
and improvement and would be keen to do further qualitative research in my future career. 
Finally, I have learnt the value of single case studies and plan to continue to use routine 
outcome measures in my clinical work so that important lessons can be learnt from those 
single cases. I feel very proud to have had one of my case studies accepted as a poster at 
the BABCP conference this year and this has highlighted to me that these smaller scaled 
projects have value too. To say I am a complete convert would be an exaggeration but I 
now look forward to finding means of keeping research alive as I enter the world of 
qualified life in busy NHS services and feel the skills I have gained mean that I am now in 
the best position possible to do so. 
 111 
 










































Appendix F: Clinical Psychology Review Author Guidelines 
 
Peer review  
This journal operates a single blind review process. All contributions will be initially 
assessed by the editor for suitability for the journal. Papers deemed suitable are then 
typically sent to a minimum of two independent expert reviewers to assess the scientific 
quality of the paper. The Editor is responsible for the final decision regarding acceptance 
or rejection of articles. The Editor's decision is final. More information on types of peer 
review. 
 
Use of word processing software  
It is important that the file be saved in the native format of the word processor used. The 
text should be in single-column format. Keep the layout of the text as simple as possible. 
Most formatting codes will be removed and replaced on processing the article. In 
particular, do not use the word processor's options to justify text or to hyphenate words. 
However, do use bold face, italics, subscripts, superscripts etc. When preparing tables, if 
you are using a table grid, use only one grid for each individual table and not a grid for 
each row. If no grid is used, use tabs, not spaces, to align columns. The electronic text 
should be prepared in a way very similar to that of conventional manuscripts (see also the 
Guide to Publishing with Elsevier). Note that source files of figures, tables and text 
graphics will be required whether or not you embed your figures in the text. See also the 
section on Electronic artwork.  
 
To avoid unnecessary errors you are strongly advised to use the 'spell-check' and 
'grammar-check' functions of your word processor. 
 
Article structure  
Manuscripts should be prepared according to the guidelines set forth in the Publication 
Manual of the American Psychological Association (6th ed., 2009). Of note, section 
headings should not be numbered. 
Manuscripts should ordinarily not exceed 50 pages, including references and tabular 
material. Exceptions may be made with prior approval of the Editor in Chief. Manuscript 
length can often be managed through the judicious use of appendices. In general the 
References section should be limited to citations actually discussed in the text. References 
to articles solely included in meta-analyses should be included in an appendix, which will 
appear in the on line version of the paper but not in the print copy. Similarly, extensive 
Tables describing study characteristics, containing material published elsewhere, or 
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presenting formulas and other technical material should also be included in an appendix. 
Authors can direct readers to the appendices in appropriate places in the text. 
It is authors' responsibility to ensure their reviews are comprehensive and as up to date as 
possible (at least through the prior calendar year) so the data are still current at the time of 
publication. Authors are referred to the PRISMA Guidelines (http://www.prisma-
statement.org/statement.htm) for guidance in conducting reviews and preparing 
manuscripts. Adherence to the Guidelines is not required, but is recommended to enhance 
quality of submissions and impact of published papers on the field. 
 
Appendices  
If there is more than one appendix, they should be identified as A, B, etc. Formulae and 
equations in appendices should be given separate numbering: Eq. (A.1), Eq. (A.2), etc.; in 
a subsequent appendix, Eq. (B.1) and so on. Similarly for tables and figures: Table A.1; 
Fig. A.1, etc. 
 
Essential title page information  
Title. Concise and informative. Titles are often used in information-retrieval systems. 
Avoid abbreviations and formulae where possible. Note: The title page should be the 
first page of the manuscript document indicating the author's names and affiliations 
and the corresponding author's complete contact information.  
 
Author names and affiliations. Where the family name may be ambiguous (e.g., a double 
name), please indicate this clearly. Present the authors' affiliation addresses (where the 
actual work was done) below the names. Indicate all affiliations with a lower-case 
superscript letter immediately after the author's name and in front of the appropriate 
address. Provide the full postal address of each affiliation, including the country name, 
and, if available, the e-mail address of each author within the cover letter. 
 
Corresponding author. Clearly indicate who is willing to handle correspondence at all 
stages of refereeing and publication, also post-publication. Ensure that telephone and 
fax numbers (with country and area code) are provided in addition to the e-mail 
address and the complete postal address.  
 
Present/permanent address. If an author has moved since the work described in the article 
was done, or was visiting at the time, a "Present address"' (or "Permanent address") may 
be indicated as a footnote to that author's name. The address at which the author actually 
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did the work must be retained as the main, affiliation address. Superscript Arabic numerals 
are used for such footnotes. 
 
Abstract  
A concise and factual abstract is required (not exceeding 200 words). This should be typed 
on a separate page following the title page. The abstract should state briefly the purpose of 
the research, the principal results and major conclusions. An abstract is often presented 
separate from the article, so it must be able to stand alone. References should therefore be 
avoided, but if essential, they must be cited in full, without reference to the reference list. 
 
Graphical abstract  
Although a graphical abstract is optional, its use is encouraged as it draws more attention 
to the online article. The graphical abstract should summarize the contents of the article in 
a concise, pictorial form designed to capture the attention of a wide readership. Graphical 
abstracts should be submitted as a separate file in the online submission system. Image 
size: Please provide an image with a minimum of 531 × 1328 pixels (h × w) or 
proportionally more. The image should be readable at a size of 5 × 13 cm using a regular 
screen resolution of 96 dpi. Preferred file types: TIFF, EPS, PDF or MS Office files. You 
can view Example Graphical Abstracts on our information site. 
 
Authors can make use of Elsevier's Illustration and Enhancement service to ensure the best 
presentation of their images and in accordance with all technical requirements:  
 
Highlights  
Highlights are mandatory for this journal. They consist of a short collection of bullet 
points that convey the core findings of the article and should be submitted in a separate 
editable file in the online submission system. Please use 'Highlights' in the file name and 
include 3 to 5 bullet points (maximum 85 characters, including spaces, per bullet point).  
 
Keywords  
Immediately after the abstract, provide a maximum of 6 keywords, using American 
spelling and avoiding general and plural terms and multiple concepts (avoid, for example, 
'and', 'of'). Be sparing with abbreviations: only abbreviations firmly established in the field 





Define abbreviations that are not standard in this field in a footnote to be placed on the 
first page of the article. Such abbreviations that are unavoidable in the abstract must be 
defined at their first mention there, as well as in the footnote. Ensure consistency of 
abbreviations throughout the article. 
 
Acknowledgements  
Collate acknowledgements in a separate section at the end of the article before the 
references and do not, therefore, include them on the title page, as a footnote to the title or 
otherwise. List here those individuals who provided help during the research (e.g., 
providing language help, writing assistance or proof reading the article, etc.). 
 
Formatting of funding sources  
List funding sources in this standard way to facilitate compliance to funder's requirements: 
Funding: This work was supported by the National Institutes of Health [grant numbers 
xxxx, yyyy]; the Bill & Melinda Gates Foundation, Seattle, WA [grant number zzzz]; and 
the United States Institutes of Peace [grant number aaaa]. 
 
It is not necessary to include detailed descriptions on the program or type of grants and 
awards. When funding is from a block grant or other resources available to a university, 
college, or other research institution, submit the name of the institute or organization that 
provided the funding. 
 
If no funding has been provided for the research, please include the following sentence: 
This research did not receive any specific grant from funding agencies in the public, 
commercial, or not-for-profit sectors. 
 
Footnotes  
Footnotes should be used sparingly. Number them consecutively throughout the article. 
Many word processors can build footnotes into the text, and this feature may be used. 
Otherwise, please indicate the position of footnotes in the text and list the footnotes 






Electronic artwork  
General points 
• Make sure you use uniform lettering and sizing of your original artwork.  
• Embed the used fonts if the application provides that option.  
• Aim to use the following fonts in your illustrations: Arial, Courier, Times New Roman, 
Symbol, or use fonts that look similar.  
• Number the illustrations according to their sequence in the text.  
• Use a logical naming convention for your artwork files.  
• Provide captions to illustrations separately.  
• Size the illustrations close to the desired dimensions of the published version.  
• Submit each illustration as a separate file. 
A detailed guide on electronic artwork is available. 
 
Formats 
If your electronic artwork is created in a Microsoft Office application (Word, PowerPoint, 
Excel) then please supply 'as is' in the native document format.  
Regardless of the application used other than Microsoft Office, when your electronic 
artwork is finalized, please 'Save as' or convert the images to one of the following formats 
(note the resolution requirements for line drawings, halftones, and line/halftone 
combinations given below):  
EPS (or PDF): Vector drawings, embed all used fonts.  
TIFF (or JPEG): Color or grayscale photographs (halftones), keep to a minimum of 300 
dpi.  
TIFF (or JPEG): Bitmapped (pure black & white pixels) line drawings, keep to a 
minimum of 1000 dpi.  
TIFF (or JPEG): Combinations bitmapped line/half-tone (color or grayscale), keep to a 
minimum of 500 dpi. 
 
Please do not:  
• Supply files that are optimized for screen use (e.g., GIF, BMP, PICT, WPG); these 
typically have a low number of pixels and limited set of colors;  
• Supply files that are too low in resolution;  
• Submit graphics that are disproportionately large for the content. 
 
Color artwork  
Please make sure that artwork files are in an acceptable format (TIFF (or JPEG), EPS (or 
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PDF), or MS Office files) and with the correct resolution. If, together with your accepted 
article, you submit usable color figures then Elsevier will ensure, at no additional charge, 
that these figures will appear in color online (e.g., ScienceDirect and other sites) 
regardless of whether or not these illustrations are reproduced in color in the printed 
version. For color reproduction in print, you will receive information regarding the 
costs from Elsevier after receipt of your accepted article. Please indicate your 
preference for color: in print or online only. Further information on the preparation of 
electronic artwork. 
 
Figure captions  
Ensure that each illustration has a caption. Supply captions separately, not attached to the 
figure. A caption should comprise a brief title (not on the figure itself) and a description of 
the illustration. Keep text in the illustrations themselves to a minimum but explain all 
symbols and abbreviations used. 
 
Tables  
Please submit tables as editable text and not as images. Tables can be placed either next to 
the relevant text in the article, or on separate page(s) at the end. Number tables 
consecutively in accordance with their appearance in the text and place any table notes 
below the table body. Be sparing in the use of tables and ensure that the data presented in 
them do not duplicate results described elsewhere in the article. Please avoid using vertical 
rules and shading in table cells. 
 
References  
Citations in the text should follow the referencing style used by the American 
Psychological Association. You are referred to the Publication Manual of the American 
Psychological Association, Sixth Edition, ISBN 1-4338-0559-6, copies of which may be 
ordered from http://books.apa.org/books.cfm?id=4200067 or APA Order Dept., P.O.B. 
2710, Hyattsville, MD 20784, USA or APA, 3 Henrietta Street, London, WC3E 8LU, UK.  
 
Citation in text  
Please ensure that every reference cited in the text is also present in the reference list (and 
vice versa). Any references cited in the abstract must be given in full. Unpublished results 
and personal communications are not recommended in the reference list, but may be 
mentioned in the text. If these references are included in the reference list they should 
follow the standard reference style of the journal and should include a substitution of the 
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publication date with either 'Unpublished results' or 'Personal communication'. Citation of 
a reference as 'in press' implies that the item has been accepted for publication. 
 
Web references  
As a minimum, the full URL should be given and the date when the reference was last 
accessed. Any further information, if known (DOI, author names, dates, reference to a 
source publication, etc.), should also be given. Web references can be listed separately 
(e.g., after the reference list) under a different heading if desired, or can be included in the 
reference list. 
 
Data references  
This journal encourages you to cite underlying or relevant datasets in your manuscript by 
citing them in your text and including a data reference in your Reference List. Data 
references should include the following elements: author name(s), dataset title, data 
repository, version (where available), year, and global persistent identifier. Add [dataset] 
immediately before the reference so we can properly identify it as a data reference. The 
[dataset] identifier will not appear in your published article. 
 
References in a special issue  
Please ensure that the words 'this issue' are added to any references in the list (and any 
citations in the text) to other articles in the same Special Issue. 
 
Reference management software  
Most Elsevier journals have their reference template available in many of the most popular 
reference management software products. These include all products that support Citation 
Style Language styles, such as Mendeley and Zotero, as well as EndNote. Using the word 
processor plug-ins from these products, authors only need to select the appropriate journal 
template when preparing their article, after which citations and bibliographies will be 
automatically formatted in the journal's style. If no template is yet available for this 
journal, please follow the format of the sample references and citations as shown in this 
Guide. 
 
Reference style  
References should be arranged first alphabetically and then further sorted chronologically 
if necessary. More than one reference from the same author(s) in the same year must be 
identified by the letters "a", "b", "c", etc., placed after the year of publication. References 
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should be formatted with a hanging indent (i.e., the first line of each reference is 
flush left while the subsequent lines are indented). 
Examples: Reference to a journal publication: Van der Geer, J., Hanraads, J. A. J., & 
Lupton R. A. (2000). The art of writing a scientific article. Journal of Scientific 
Communications, 163, 51-59. 
Reference to a book: Strunk, W., Jr., &White, E. B. (1979). The elements of style. (3rd 
ed.). New York: Macmillan, (Chapter 4). 
Reference to a chapter in an edited book: Mettam, G. R., & Adams, L. B. (1994). How to 
prepare an electronic version of your article. In B.S. Jones, & R. Z. Smith (Eds.), 
Introduction to the electronic age (pp. 281-304). New York: E-Publishing Inc. 
[dataset] Oguro, M., Imahiro, S., Saito, S., Nakashizuka, T. (2015). Mortality data for 
Japanese oak wilt disease and surrounding forest compositions. Mendeley Data, v1.  
 
Video  
Elsevier accepts video material and animation sequences to support and enhance your 
scientific research. Authors who have video or animation files that they wish to submit 
with their article are strongly encouraged to include links to these within the body of the 
article. This can be done in the same way as a figure or table by referring to the video or 
animation content and noting in the body text where it should be placed. All submitted 
files should be properly labeled so that they directly relate to the video file's content. In 
order to ensure that your video or animation material is directly usable, please provide the 
files in one of our recommended file formats with a preferred maximum size of 150 MB. 
Video and animation files supplied will be published online in the electronic version of 
your article in Elsevier Web products, including ScienceDirect. Please supply 'stills' with 
your files: you can choose any frame from the video or animation or make a separate 
image. These will be used instead of standard icons and will personalize the link to your 
video data. For more detailed instructions please visit our video instruction pages. Note: 
since video and animation cannot be embedded in the print version of the journal, please 
provide text for both the electronic and the print version for the portions of the article that 
refer to this content. 
 
Supplementary material  
Supplementary material such as applications, images and sound clips, can be published 
with your article to enhance it. Submitted supplementary items are published exactly as 
they are received (Excel or PowerPoint files will appear as such online). Please submit 
your material together with the article and supply a concise, descriptive caption for each 
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supplementary file. If you wish to make changes to supplementary material during any 
stage of the process, please make sure to provide an updated file. Do not annotate any 
corrections on a previous version. Please switch off the 'Track Changes' option in 
Microsoft Office files as these will appear in the published version. 
 
RESEARCH DATA  
This journal encourages and enables you to share data that supports your research 
publication where appropriate, and enables you to interlink the data with your published 
articles. Research data refers to the results of observations or experimentation that validate 
research findings. To facilitate reproducibility and data reuse, this journal also encourages 
you to share your software, code, models, algorithms, protocols, methods and other useful 
materials related to the project. 
 
Below are a number of ways in which you can associate data with your article or make a 
statement about the availability of your data when submitting your manuscript. If you are 
sharing data in one of these ways, you are encouraged to cite the data in your manuscript 
and reference list. Please refer to the "References" section for more information about data 
citation. For more information on depositing, sharing and using research data and other 
relevant research materials, visit the research data page. 
 
Data linking  
If you have made your research data available in a data repository, you can link your 
article directly to the dataset. Elsevier collaborates with a number of repositories to link 
articles on ScienceDirect with relevant repositories, giving readers access to underlying 
data that give them a better understanding of the research described. 
There are different ways to link your datasets to your article. When available, you can 
directly link your dataset to your article by providing the relevant information in the 
submission system. For more information, visit the database linking page. 
For supported data repositories a repository banner will automatically appear next to your 
published article on ScienceDirect. 
 
This journal supports Mendeley Data, enabling you to deposit any research data (including 
raw and processed data, video, code, software, algorithms, protocols, and methods) 
associated with your manuscript in a free-to-use, open access repository. During the 
submission process, after uploading your manuscript, you will have the opportunity to 
upload your relevant datasets directly to Mendeley Data. The datasets will be listed and 
 124
directly accessible to readers next to your published article online. 
For more information, visit the Mendeley Data for journals page. 
 
Transparency  
To foster transparency, we encourage you to state the availability of your data in your 
submission. If your data is unavailable to access or unsuitable to post, this gives you the 
opportunity to indicate why. If you submit this form with your manuscript as a 






The journal encourages authors to create an AudioSlides presentation with their published 
article. AudioSlides are brief, webinar-style presentations that are shown next to the online 
article on ScienceDirect. This gives authors the opportunity to summarize their research in 
their own words and to help readers understand what the paper is about. More information 
and examples are available. Authors of this journal will automatically receive an invitation 
e-mail to create an AudioSlides presentation after acceptance of their paper. 
 
3D neuroimaging  
You can enrich your online articles by providing 3D neuroimaging data in NIfTI format. 
This will be visualized for readers using the interactive viewer embedded within your 
article, and will enable them to: browse through available neuroimaging datasets; zoom, 
rotate and pan the 3D brain reconstruction; cut through the volume; change opacity and 
color mapping; switch between 3D and 2D projected views; and download the data. The 
viewer supports both single (.nii) and dual (.hdr and .img) NIfTI file formats. 
Recommended size of a single uncompressed dataset is maximum 150 MB. Multiple 
datasets can be submitted. Each dataset will have to be zipped and uploaded to the online 
submission system via the '3D neuroimaging data' submission category. Please provide a 
short informative description for each dataset by filling in the 'Description' field when 
uploading a dataset. Note: all datasets will be available for downloading from the online 
article on ScienceDirect. If you have concerns about your data being downloadable, please 
provide a video instead. 
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Appendix M: Journal of Cystic Fibrosis Author Guidelines 
 
Journal of Cystic Fibrosis publishes original scientific articles, editorials, case reports, 
short communications and other information relevant to cystic fibrosis and is published six 
times a year. Papers are accepted on the understanding that they have not been published, 
and are not being considered for publication elsewhere and are subject to editorial 
revision. 
 
Original articles Original research papers should contain no more than 3,000 words plus 
no more than 5 figures or tables in total and 30 references. The abstract should consist of 4 
paragraphs, labelled Background, Methods, Results, and Conclusions. 
 
Review articles Review papers should be authoritative, well-referenced reviews of a 
relevant subject and should not contain more than 5,000 words and 30 references with no 
more than 6 figures or tables. 
 
Letters Headings should not be used in a letter; no abstract or keywords are required. The 
text should be no more than 800 words; there should be a maximum of 5 references and 1 
table or figure may be included. 
 
Correspondence Short articles relating to papers recently published in the Journal, or 
containing brief reports of unusual or preliminary findings. Maximum length 400 words, 1 
table or figure and a maximum of 10 references. 
 
Editorials These tend to be invited papers but unsolicited editorials are welcome. There 
are no abstract, keywords or section headings. 
 
Short Communications 1,200 words plus no more than 3 figures or tables in total and 20 
references. 
 
Case Reports These must be carefully documented and must be of importance because 
they illustrate or describe unusual features or have important therapeutic implications. 
Maximum length 1,200 words, no more than a page and a half in length and a maximum 
of 1 table or figure. Case reports do not require a structured abstract and should include no 
more than 5 references. 
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Ensure that the following items are present: 
One author has been designated as the corresponding author with contact details: 
• E-mail address 
• Full postal address 
 
All necessary files have been uploaded: 
Manuscript: 
• Include keywords 
• All figures (include relevant captions) 
• All tables (including titles, description, footnotes) 
• Ensure all figure and table citations in the text match the files provided 
• Indicate clearly if color should be used for any figures in print 
Graphical Abstracts / Highlights files (where applicable) 
Supplemental files (where applicable) 
 
Further considerations 
• Manuscript has been 'spell checked' and 'grammar checked' 
• All references mentioned in the Reference List are cited in the text, and vice versa 
• Permission has been obtained for use of copyrighted material from other sources 
(including the Internet) 
• Relevant declarations of interest have been made 
• Journal policies detailed in this guide have been reviewed 
• Referee suggestions and contact details provided, based on journal requirements 
 
Ethics in publishing  
Work on human beings that is submitted to Respiratory Medicine should comply with the 
principles laid down in the Declaration of Helsinki; Recommendations guiding physicians 
in biomedical research involving human subjects. Adopted by the 18th World Medical 
Assembly, Helsinki, Finland, June 1964, amended by the 29th World Medical Assembly, 
Tokyo, Japan, October 1975, the 35th World Medical Assembly, Venice, Italy, October 
1983, and the 41st World Medical Assembly, Hong Kong, September 1989. The 
manuscript should contain a statement that the work has been approved by the appropriate 
ethical committees related to the institution(s) in which it was performed and that subjects 
gave informed consent to the work. Studies involving experiments with animals must state 
that their care was in accordance with institution guidelines. Patients' and volunteers' 
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names, initials, and hospital numbers should not be used. 
Declaration of interest  
All authors must disclose any financial and personal relationships with other people or 
organizations that could inappropriately influence (bias) their work. Examples of potential 
conflicts of interest include employment, consultancies, stock ownership, honoraria, paid 
expert testimony, patent applications/registrations, and grants or other funding. If there are 
no conflicts of interest then please state this: 'Conflicts of interest: none'. 
 
Submission declaration and verification  
Submission of an article implies that the work described has not been published previously 
(except in the form of an abstract or as part of a published lecture or academic thesis or as 
an electronic preprint, see 'Multiple, redundant or concurrent publication' section of our 
ethics policy for more information), that it is not under consideration for publication 
elsewhere, that its publication is approved by all authors and tacitly or explicitly by the 
responsible authorities where the work was carried out, and that, if accepted, it will not be 
published elsewhere in the same form, in English or in any other language, including 
electronically without the written consent of the copyright-holder. To verify originality, 
your article may be checked by the originality detection service CrossCheck. 
 
Authorship  
All authors should have made substantial contributions to all of the following: (1) the 
conception and design of the study, or acquisition of data, or analysis and interpretation of 
data, (2) drafting the article or revising it critically for important intellectual content, (3) 
final approval of the version to be submitted. 
 
Changes to authorship  
Authors are expected to consider carefully the list and order of authors before submitting 
their manuscript and provide the definitive list of authors at the time of the original 
submission. Any addition, deletion or rearrangement of author names in the authorship list 
should be made only before the manuscript has been accepted and only if approved by the 
journal Editor. To request such a change, the Editor must receive the following from the 
corresponding author: (a) the reason for the change in author list and (b) written 
confirmation (e-mail, letter) from all authors that they agree with the addition, removal or 
rearrangement. In the case of addition or removal of authors, this includes confirmation 
from the author being added or removed. 
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Only in exceptional circumstances will the Editor consider the addition, deletion or 
rearrangement of authors after the manuscript has been accepted. While the Editor 
considers the request, publication of the manuscript will be suspended. If the manuscript 
has already been published in an online issue, any requests approved by the Editor will 
result in a corrigendum. 
 
Copyright  
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing 
Agreement' (see more information on this). An e-mail will be sent to the corresponding 
author confirming receipt of the manuscript together with a 'Journal Publishing 
Agreement' form or a link to the online version of this agreement. 
 
Subscribers may reproduce tables of contents or prepare lists of articles including abstracts 
for internal circulation within their institutions. Permission of the Publisher is required for 
resale or distribution outside the institution and for all other derivative works, including 
compilations and translations. If excerpts from other copyrighted works are included, the 
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Text: Indicate references by number(s) in square brackets in line with the text. The actual 
authors can be referred to, but the reference number(s) must always be given.  
List: Number the references (numbers in square brackets) in the list in the order in which 
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Commun 2010;163:51–9.  
Reference to a book:  
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article. This can be done in the same way as a figure or table by referring to the video or 
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files in one of our recommended file formats with a preferred maximum size of 150 MB. 
Video and animation files supplied will be published online in the electronic version of 
your article in Elsevier Web products, including ScienceDirect. Please supply 'stills' with 
your files: you can choose any frame from the video or animation or make a separate 
image. These will be used instead of standard icons and will personalize the link to your 
video data. For more detailed instructions please visit our video instruction pages. Note: 
since video and animation cannot be embedded in the print version of the journal, please 
provide text for both the electronic and the print version for the portions of the article that 
refer to this content. 
 
Supplementary material  
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they are received (Excel or PowerPoint files will appear as such online). Please submit 
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supplementary file. If you wish to make changes to supplementary material during any 
stage of the process, please make sure to provide an updated file. Do not annotate any 
corrections on a previous version. Please switch off the 'Track Changes' option in 
Microsoft Office files as these will appear in the published version. 
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any changes made to the original submission are easily visible to the Editors. Those 
revised manuscripts upon which the changes are not clear may be returned to the author. 
Specific comments made in the Author Comments in response to referees' comments must 
be organised clearly. For example, use the same numbering system as the referee, or use 2 





















Appendix O: Main Research Project Patient Information Sheet – MCI Group 
 
Participant Information Sheet – MCI Group                                                                 
17.06.16 (version 2) 
 
The Role of Health Anxiety in Mild Cognitive Impairment 
 
We would like to invite you to take part in our research project. Please take your 
time to read this information sheet and feel free to talk it through with others 
before you make a decision should you so wish. 
 
What is the purpose of the project? 
The project aims to explore the relationship between receiving a diagnosis of a 
Mild Cognitive Impairment and how worried people feel about their health (health 
anxiety). Mild Cognitive Impairment (MCI) is a term used to describe the 
experience of having difficulties with your thinking (e.g. memory problems) that 
are detected on tests but do not meet the criteria for a dementia. Some people 
who are told that they have an MCI go on to develop a dementia whilst others do 
not. This can make MCI a very uncertain diagnosis to receive and we are 
interested in whether this uncertainty makes people more or less worried about 
their health. 
 
In order to understand if having an MCI specifically influences peoples’ worries 
about their health, we will also be looking at how worried people who do not have 
MCI feel about their health. This will allow us to compare people with and without 
MCI. 
 
Why have I been invited? 
You have been invited to take part because you are an adult over the age of 50 
years old and have been diagnosed with MCI following an assessment from an 
NHS memory service. 
 
Do I have to take part? 
No. Taking part in this project is entirely voluntary. You also have the right to 
withdraw from the project at any time during the study. If you withdraw, any 
information we have collected from you will be destroyed. 
 
What will happen to me if I do decide to take part? 
You will be asked to complete four short questionnaires about your overall mood, 
how worried you feel about your health and your views on MCI. You will then be 
asked to take part in a short interview with the researcher who will ask you 
questions about your perception of your quality of life. Finally you will be asked to 
complete two short tests of your thinking and rate your performance on these tests 
afterwards. 
 
We will also ask you to identify a family member/spouse/friend who knows you 
well to complete a short questionnaire about how they feel you manage day to 
day tasks (e.g. household chores, eating and drinking, cooking etc.). If you 
choose to bring someone with you to the appointment, we can ask them to 
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complete this at the same time. Alternatively, it can be completed with someone 
on the phone at a later date. 
Taking part in this study is estimated to last around 1 – 2 hours. We will only need 
to meet with you once. We can meet at your local memory service, GP surgery 
(subject to approval), the University of Bath or within your own home. It will be 
conducted by Rachel Phillips (Clinical Psychologist in training, Bath University) 
who is the named researcher on this project.  
 
What are the benefits of taking part? 
We cannot promise that the project will have any direct benefit for you. However, 
we hope that the information that we get from this project will allow us to better 
understand the experience of and potential consequences of receiving a 
diagnosis of MCI. We hope that these results will better inform professionals 
working with people who are concerned about their thinking in how they best 
communicate the results of their assessments to individuals. We also hope that it 
will highlight potential support needs of people with MCI beyond what it is 
currently provided. 
 
What are the potential risks of taking part? 
Although we do not anticipate participating in the study to be a distressing 
process, we so recognise that the topics covered by this project can be quite 
sensitive ones and so support is available should you feel concerned following 
your participation. This research is supervised by two Clinical Psychologists 
whose contact details are at the end of this information sheet if you wished to 
discuss any concerns you may have with them. You can also discuss any 
concerns you have directly with the researcher. In addition you will be provided 
with contact details of third party organisations that would also be able to offer 
support and guidance.  
 
What happens with my information? 
All of the information that we collect is kept confidential. Each person who takes 
part in the study will be assigned an anonymous participant number and personal 
details such as names and addresses will not be recorded or included in any 
written reports. Electronic reports will be kept on password protected computers. 
Paper records will be kept in a locked cabinet which is only accessible by the 
researcher and the research supervisors. 
 
We are interested in exploring the possibility of completing a follow up study at a 
later date. As such we would like to securely store data from this study at the 
University of Bath for a period of up to 5 years to allow for the potential of a follow 
up study to be pursued. In the event of a follow up study taking place, you will be 
contacted directly to provide consent prior to its start. Should you decide that you 
do not want us to store your data for this purpose, this will not affect your ability to 
take part in the current study. 
 
What if there is a problem? 
If you have any concerns or wish to complain about any aspect of this project, you 
should initially contact the researcher, Rachel Phillips, who will do her best to 
address your concerns. Her contact details are provided at the end of this 
information sheet. If you remain unhappy and wish to complain formally, you can 
do this by contacting, the University of Bath Secretary Mark Humphriss on 01225 
286212 or universitysec@bath.ac.uk. The University of Bath, as Sponsor of the 
study, has indemnity (insurance) arrangements in place. Every care will be taken 




What will happen to the findings of the project? 
The findings will help inform the professional literature around the experience of 
receiving a diagnosis of MCI and may lead to further projects in the area. We also 
hope it will inform services as to how they may best shape their clinical practice. 
The results will be written up into a report to be submitted for publication in a 
professional journal which would be available to a large amount of people. The 
write up will be confidential and you will not be identifiable. If you want to receive a 
copy of the results, please let the researcher know who can send them to you on 
completion. 
 
For more information, please contact the researcher: 
Rachel Phillips 
Clinical Psychologist in training 
Department of Psychology 






The project is supervised by Professor Paul Salkovskis (Programme Director and 
Clinical Psychologist, The University of Bath; p.m.salkovskis@bath.ac.uk) and Dr 
Orazio Giuffrida (Clinical Psychologist, Herefordshire Memory Service; 
orazio.giuffrida@nhs.net). 
 







Appendix P: Main Research Project Patient Information Sheet – Healthy Controls 
 
Participant Information Sheet – Control Group                                                                                                  
17.06.16 (version 1) 
 
The Role of Health Anxiety in Mild Cognitive Impairment 
 
We would like to invite you to take part in our research project. Please take your 
time to read this information sheet and feel free to talk it through with others 
before you make a decision should you so wish. 
 
What is the purpose of the project? 
The project aims to explore the relationship between receiving a diagnosis of a 
Mild Cognitive Impairment and how worried people feel about their health (health 
anxiety). Mild Cognitive Impairment (MCI) is a term used to describe the 
experience of having difficulties with your thinking (e.g. memory problems) that 
are detected on tests but do not meet the criteria for a dementia. Some people 
who are told that they have an MCI go on to develop a dementia whilst others do 
not. This can make MCI a very uncertain diagnosis to receive and we are 
interested in whether this uncertainty makes people more or less worried about 
their health. 
 
In order to understand if having an MCI specifically influences peoples’ worries 
about their health, we are also interested in looking at how worried people who do 
not have MCI feel about their health. This will allow us to compare people with 
and without MCI. 
 
Why have I been invited? 
You have been invited to take part because you are an adult over the age of 50 
years old who does not have any diagnosed problems with their thinking (i.e. you 
do not have MCI, a dementia or any other neurological problem). 
 
Do I have to take part? 
No. Taking part in this project is entirely voluntary. You also have the right to 
withdraw from the project at any time during the study. If you withdraw, any 
information we have collected from you will be destroyed. 
 
What will happen to me if I do decide to take part? 
Firstly, you will be asked to complete a short screening task to ensure that you do 
not have any difficulties with your thinking. This screening task is made up of a 
number of brief pen and paper tests that look at different areas of your thinking, 
such as memory, attention and language. Scores of 26 or above (maximum score 
of 30) on the screening task will mean that people are eligible to take part in the 
remainder of the study, Scores falling below 26 would mean that you could not 
take part in the rest of the research. Please see the ‘What are the risks of taking 
part?’ section below for further details of what happens in the event that your 
score falls below 26. 
 
Following the screening task, you will be asked to complete four short 
questionnaires about your overall mood, how worried you feel about your health 
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and your views on illness. You will then be asked to take part in a short interview 
with the researcher who will ask you questions about your perception of your 
quality of life. Finally you will be asked to complete two short tests of your thinking 
and rate your performance on these tests afterwards. 
 
We will also ask you to identify a family member/spouse/friend who knows you 
well to complete a short questionnaire about how they feel you manage day to 
day tasks (e.g. household chores, eating and drinking, cooking etc.). If you 
choose to bring someone with you to the appointment, we can ask them to 
complete this at the same time. Alternatively, it can be completed with someone 
on the phone at a later date. 
 
Taking part in this study is estimated to last around 1 – 2 hours. We will only need 
to meet with you once. We can meet at your GP surgery (subject to approval), the 
University of Bath or within your own home. It will be conducted by Rachel Phillips 
(Clinical Psychologist in training, Bath University) who is the named researcher on 
this project.  
 
What are the benefits of taking part? 
We cannot promise that the project will have any direct benefit for you. However, 
we hope that the information that we get from this project will allow us to better 
understand the experience of and potential consequences of receiving a 
diagnosis of MCI. We hope that these results will better inform professionals 
working with people who are concerned about their thinking in how they best 
communicate the results of their assessments with individuals. We also hope that 
it will highlight potential support needs of people with MCI beyond what it is 
currently provided. 
 
What are the potential risks of taking part? 
Although we do not anticipate this to be a frequent outcome, it is possible that the 
screening test may suggest that you have some difficulties with your thinking. If 
this is indicated, then we would ask for your consent to send a copy of our tests 
with an accompanying letter to your GP to explain your role in the research and 
ask them to arrange a time to meet with you to discuss these results further. They 
would then be able to discuss with you the possibility of a referral to your local 
memory clinic for further investigation into this if you wanted them to. If you did not 
want us to contact your GP with this information then we would ask for your 
consent to give you a follow up telephone call in 1-2 weeks time to check whether 
you would like any further support. 
 
This research is supervised by two Clinical Psychologists whose contact details 
are at the end of this information sheet if you wished to discuss any concerns you 
may have with them. You can also discuss any concerns you have directly with 
the researcher. In addition you will be provided with contact details of third party 
organisations that would also be able to offer support and guidance. These 
resources could also be used should you find the process of the research 
distressing. Although we do not anticipate this to be a distressing process, we 
recognise that the topics covered by this project can be quite sensitive ones and 
so support is available should you feel concerned following your participation. 
 
What happens with my information? 
All of the information that we collect is kept confidential. Each person who takes 
part in the study will be assigned an anonymous participant number and personal 
details such as names and addresses will not be recorded or included in any 
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written reports. Electronic reports will be kept on password protected computers. 
Paper records will be kept in a locked cabinet which is only accessible by the 
researcher and the research supervisors. 
 
We are interested in exploring the possibility of completing a follow up study at a 
later date. As such we would like to securely store data from this study at the 
University of Bath for a period of up to 5 years to allow for the potential of a follow 
up study to be pursued. In the event of a follow up study taking place, you will be 
contacted directly to provide consent prior to its start. Should you decide that you 
do not want us to store your data for this purpose, this will not affect your ability to 
take part in the current study. 
 
What if there is a problem? 
If you have any concerns or wish to complain about any aspect of this project, you 
should initially contact the researcher, Rachel Phillips, who will do her best to 
address your concerns. Her contact details are provided at the end of this 
information sheet. If you remain unhappy and wish to complain formally, you can 
do this by contacting, the University of Bath Secretary Mark Humphriss on 01225 
286212 or universitysec@bath.ac.uk. The University of Bath, as Sponsor of the 
study, has indemnity (insurance) arrangements in place. Every care will be taken 
to ensure your wellbeing during the course of this project. 
 
What will happen to the findings of the project? 
The findings will help inform the professional literature around the experience of 
receiving a diagnosis of MCI and may lead to further projects in the area. We also 
hope it will inform services as to how they may best shape their clinical practice. 
The results will be written up into a report to be submitted for publication in a 
professional journal which would be available to a large amount of people. The 
write up will be confidential and you will not be identifiable. If you want to receive a 
copy of the results, please let the researcher know who can send them to you on 
completion. 
 
For more information, please contact the researcher: 
Rachel Phillips 
Clinical Psychologist in training 
Department of Psychology 






The project is supervised by Professor Paul Salkovskis (Programme Director and 
Clinical Psychologist, The University of Bath; p.m.salkovskis@bath.ac.uk) and Dr 










Appendix Q: Main Research Project Consent Form 
 
Version 1, 23.04.16 
 
 
Centre Number:  
Study Number:  
Patient Identification Number for this trial:  
 
CONSENT FORM 
Title of Project: The role of Health Anxiety in Mild Cognitive Impairment 
Name of Researcher: Rachel Phillips (Clinical Psychologist in training) 
  
Please initial box 
 
1. I confirm that I have read and understand the information sheet 
dated.................... (version.......................) for the above study. I 
have had the opportunity to consider the information, ask 
questions and have had these answered satisfactorily.  
 
2. I understand that my participation is voluntary and that I am free 
to withdraw at any time without giving any reason, without my 
medical care or legal rights being affected.  
 
3. I agree for the researcher (Rachel Phillips) and her supervisors to 
have access to the information produced from my responses for 
the purposes of this study 
 
4. I agree for the researcher (Rachel Phillips) to contact my 
spouse/partner/relative/close friend (please delete as appropriate) 
to ask them to complete a questionnaire giving their views on my 
day to day functioning. I understand that their responses will be 
used for the purpose of this study. 
 
 
5.  I agree to take part in the above study.  
 
 
6. I agree to my data being securely stored by the University of Bath 
for a period of up to 5 years to allow for the potential of a follow up 
study to be pursued. In the event of this study taking place, I 
understand that I will be contacted directly to provide consent prior to its start. I 
understand that should I choose to decline for my details to be stored, this will 





__________________  ____________ ___________________ 




__________________  _____________ ____________________ 
Name of Person taking consent  Date    Signature  
 
 








































































Appendix W: Self-ratings of task performance/attribution 
 
The role of health anxiety in MCI (version 1: 10.05.16)                                                                          
 
 
Self-ratings of performance on tasks 
 
 
Please rate on the scale below how well you believed you 
performed on the two tasks that you just completed, when 





Task 1: Memory test (remembering word pairs) 
 

















Task 2: Picture completion test (what is missing in the pictures) 
 























We are also interested in how much of a role you believe your 
diagnosed Mild Cognitive Impairment (MCI) played in your 
performance today. Please rate on the scale below the degree to 
which you believe your performance would have changed if you 




Task 1: Memory test (remembering word pairs) 
 

















Task 2: Picture completion test (what is missing in the pictures) 
 















Appendix X: British Journal of Clinical Psychology Author Guidelines 
 
The British Journal of Clinical Psychology publishes original contributions to scientific 
knowledge in clinical psychology. This includes descriptive comparisons, as well as 
studies of the assessment, aetiology and treatment of people with a wide range of 
psychological problems in all age groups and settings. The level of analysis of studies 
ranges from biological influences on individual behaviour through to studies of 
psychological interventions and treatments on individuals, dyads, families and groups, to 
investigations of the relationships between explicitly social and psychological levels of 
analysis. 
 
All papers published in The British Journal of Clinical Psychology are eligible for Panel 
A: Psychology, Psychiatry and Neuroscience in the Research Excellence Framework 
(REF). 
 
The following types of paper are invited:  
• Papers reporting original empirical investigations  
• Theoretical papers, provided that these are sufficiently related to the empirical data  
• Review articles which need not be exhaustive but which should give an interpretation of 
the state of the research in a given field and, where appropriate, identify its clinical 
implications  
• Brief reports and comments  
 
1. Circulation  
The circulation of the Journal is worldwide. Papers are invited and encouraged from 
authors throughout the world.  
 
2. Length  
The word limit for papers submitted for consideration to BJCP is 5000 words and any 
papers that are over this word limit will be returned to the authors. The word limit does not 
include the abstract, reference list, figures, or tables. Appendices however are included in 
the word limit. The Editors retain discretion to publish papers beyond this length in cases 
where the clear and concise expression of the scientific content requires greater length. In 




3. Submission and reviewing  
All manuscripts must be submitted via Editorial Manager. The Journal operates a policy of 
anonymous (double blind) peer review. We also operate a triage process in which 
submissions that are out of scope or otherwise inappropriate will be rejected by the editors 
without external peer review to avoid unnecessary delays. Before submitting, please read 
the terms and conditions of submissionand the declaration of competing interests. You 
may also like to use the Submission Checklist to help you prepare your paper.  
 
4. Manuscript requirements  
• Contributions must be typed in double spacing with wide margins. All sheets must be 
numbered.  
• Manuscripts should be preceded by a title page which includes a full list of authors and 
their affiliations, as well as the corresponding author's contact details. You may like to 
use  this template. When entering the author names into Editorial Manager, the 
corresponding author will be asked to provide a CRediT contributor role to classify the 
role that each author played in creating the manuscript. Please see the Project 
CRediT website for a list of roles.  
• The main document must be anonymous. Please do not mention the authors’ names or 
affiliations (including in the Method section) and refer to any previous work in the third 
person.  
• Tables should be typed in double spacing, each on a separate page with a self-
explanatory title. Tables should be comprehensible without reference to the text. They 
should be placed at the end of the manuscript but they must be mentioned in the text.  
• Figures can be included at the end of the document or attached as separate files, carefully 
labelled in initial capital/lower case lettering with symbols in a form consistent with text 
use. Unnecessary background patterns, lines and shading should be avoided. Captions 
should be listed on a separate sheet. The resolution of digital images must be at least 300 
dpi. All figures must be mentioned in the text.  
• All papers must include a structured abstract of up to 250 words under the headings: 
Objectives, Methods, Results, Conclusions. Articles which report original scientific 
research should also include a heading 'Design' before 'Methods'. The 'Methods' section 
for systematic reviews and theoretical papers should include, as a minimum, a description 
of the methods the author(s) used to access the literature they drew upon. That is, the 
abstract should summarize the databases that were consulted and the search terms that 
were used.  
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• All Articles must include Practitioner Points – these are 2–4 bullet points to detail the 
positive clinical implications of the work, with a further 2–4 bullet points outlining 
cautions or limitations of the study. They should be placed below the abstract, with the 
heading ‘Practitioner Points’.  
• For reference citations, please use APA style. Particular care should be taken to ensure 
that references are accurate and complete. Give all journal titles in full and provide DOI 
numbers where possible for journal articles.  
• SI units must be used for all measurements, rounded off to practical values if 
appropriate, with the imperial equivalent in parentheses.  
• In normal circumstances, effect size should be incorporated.  
• Authors are requested to avoid the use of sexist language.  
• Authors are responsible for acquiring written permission to publish lengthy quotations, 
illustrations, etc. for which they do not own copyright. For guidelines on editorial style, 
please consult the APA Publication Manual published by the American Psychological 
Association.  
 
5. Brief reports and comments  
These allow publication of research studies and theoretical, critical or review comments 
with an essential contribution to make. They should be limited to 2000 words, including 
references. The abstract should not exceed 120 words and should be structured under these 
headings: Objective, Method, Results, Conclusions. There should be no more than one 
table or figure, which should only be included if it conveys information more efficiently 
than the text. Title, author name and address are not included in the word limit.  
 
6. Supporting Information  
BJC is happy to accept articles with supporting information supplied for online only 
publication. This may include appendices, supplementary figures, sound files, videoclips 
etc. These will be posted on Wiley Online Library with the article. The print version will 
have a note indicating that extra material is available online. Please indicate clearly on 
submission which material is for online only publication. Please note that extra online only 
material is published as supplied by the author in the same file format and is not 
copyedited or typeset.  
 
7. Copyright and licenses  
If your paper is accepted, the author identified as the formal corresponding author for the 
paper will receive an email prompting them to login into Author Services, where via the 
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Wiley Author Licensing Service (WALS) they will be able to complete the license 
agreement on behalf of all authors on the paper.  
 
For authors signing the copyright transfer agreement 
If the OnlineOpen option is not selected the corresponding author will be presented with 
the copyright transfer agreement (CTA) to sign. The terms and conditions of the CTA can 
be previewed in the samples associated with the Copyright FAQs.  
 
For authors choosing OnlineOpen 
If the OnlineOpen option is selected the corresponding author will have a choice of the 
following Creative Commons License Open Access Agreements (OAA):  
- Creative Commons Attribution Non-Commercial License OAA  
- Creative Commons Attribution Non-Commercial -NoDerivs License OAA  
 
If you select the OnlineOpen option and your research is funded by The Wellcome Trust 
and members of the Research Councils UK (RCUK) or the Austrian Science Fund (FWF) 
you will be given the opportunity to publish your article under a CC-BY license 
supporting you in complying with your Funder requirements.  
 
8. Colour illustrations  
Colour illustrations can be accepted for publication online. These would be reproduced in 
greyscale in the print version. If authors would like these figures to be reproduced in 
colour in print at their expense they should request this by completing a Colour Work 
Agreement form upon acceptance of the paper.  
 
9. Pre-submission English-language editing  
Authors for whom English is a second language may choose to have their manuscript 
professionally edited before submission to improve the English. 
 
10. Author Services  
Author Services enables authors to track their article – once it has been accepted – through 
the production process to publication online and in print. Authors can check the status of 
their articles online and choose to receive automated e-mails at key stages of production. 
The author will receive an e-mail with a unique link that enables them to register and have 
their article automatically added to the system. Please ensure that a complete e-mail 
address is provided when submitting the manuscript.  
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11. The Later Stages  
The corresponding author will receive an email alert containing a link to a web site. A 
working e-mail address must therefore be provided for the corresponding author. The 
proof can be downloaded as a PDF (portable document format) file from this site. Acrobat 
Reader will be required in order to read this file.  
 
This will enable the file to be opened, read on screen and annotated direct in the PDF. 
Corrections can also be supplied by hard copy if preferred. Further instructions will be 
sent with the proof. Excessive changes made by the author in the proofs, excluding 
typesetting errors, will be charged separately.  
 
12. Early View  
British Journal of Clinical Psychology is covered by the Early View service on Wiley 
Online Library. Early View articles are complete full-text articles published online in 
advance of their publication in a printed issue. Articles are therefore available as soon as 
they are ready, rather than having to wait for the next scheduled print issue. Early View 
articles are complete and final. They have been fully reviewed, revised and edited for 
publication, and the authors’ final corrections have been incorporated. Because they are in 
final form, no changes can be made after online publication. The nature of Early View 
articles means that they do not yet have volume, issue or page numbers, so they cannot be 
cited in the traditional way. They are cited using their Digital Object Identifier (DOI) with 
no volume and issue or pagination information. E.g., Jones, A.B. (2010). Human rights 
Issues.  Human Rights Journal. Advance online publication. doi:10.1111/j.1467-
9299.2010.00300.x 
 
